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INTERVENTIONS FOR IMPROVING EMPLOYMENT OUTCOMES FOR WORKERS 
WITH HIV: A COCHRANE SYSTEMATIC REVIEW 
HIV infection, specifically in the working age population, is a major public health and economic 
problem. The objective of this review was to evaluate the effect of interventions aimed at 
sustaining and improving employment in HIV+ persons. We conducted a comprehensive search 
from 1981 until December 2014 in the following databases: Cochrane Central Register of 
Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, OSH UPDATE databases 
(CISDOC, HSELINE, NIOSHTIC, NIOSHTIC-2, RILOSH), and PsycINFO. We considered 
for inclusion all randomized controlled trials (RCTs) or controlled before-after (CBA) studies 
assessing the effectiveness of pharmacological, vocational and psychological interventions with 
HIV+ working-aged (16 years or older) participants that had used indices of employment as 
outcomes. Two review authors independently screened all potential references and final 
selection of studies was determined by consensus. We performed data extraction and ‘Risk of 
bias’ assessment with the Downs & Black checklist, in duplicate. We measured the treatment 
effect using odds ratio (OR) for binary outcomes and mean difference (MD) for continuous 
outcomes. We applied the GRADE approach to appraise the quality of the evidence. We found 
one RCT with 174 participants and five CBAs with 48,058 participants assessing the 
effectiveness of vocational training (n = 1) and antiretroviral therapy (ART) (n = 5). We found 
no studies assessing psychological interventions. The one RCT was conducted in the United 
States; the five CBA studies were conducted in South Africa, India, Kenya, and Uganda. For 
vocational intervention, in one study we could not infer the intervention effect due to a lack of 
data. For pharmacological interventions, due to differences in outcome measures, we could only 
combine the results of two studies in a meta-analysis. Two studies compared employment 
outcomes of HIV+ persons on ART therapy to healthy controls. One study found a MD of - 1.22 
days worked per month (95% confidence interval (CI) -1.74 to -1.07) at 24-months follow-up. 
The other study found that the likelihood of being employed steadily increased for HIV+ persons 
compared to healthy individuals from ART initiation (OR 0.35, 95% CI 0.26 to 0.47) to three- 
to five-years follow-up (OR 0.73, 95% CI 0.42 to 1.28). Three other studies compared HIV+ 
persons on ART to HIV+ persons not yet on ART. Two studies indicated an increased likelihood 
of employment due to ART for HIV+ persons on ART (OR 1.75 95% CI 1.44 to 2.12). One 
study found that the group on ART worked 12.1 hours (95% CI 6.99 to 17.21) more per week 
at 24-months follow-up. The evidence was rated as very low quality for all comparisons due to 
a high risk of bias. Overall, we found very low-quality evidence showing that ART interventions 
may improve employment outcomes for HIV+ persons. We need more high-quality, preferably 
randomized studies, to assess the effectiveness of RTW interventions for HIV+ persons.  
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ABBREVIATIONS 
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CBA  Controlled Before-After study 
HAART Highly Active Antiretroviral Therapy 
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PLWH  People Living with HIV¹  
RCT  Randomized Control Trial 
RR  Risk Ratio 
RTW   Return to work 
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TNFCCP Tamil Nadu Family Care Continuum Program  
WHO  World Health Organization 
 
 
 
 
 
 
 
 
 
 
 
¹ The terminology ‘PLWH’ was used in a few publications, interchangeably with HIV+ persons. 
For the sake of readability, we will use ‘HIV+ persons’ throughout the majority of the thesis.
1 INTRODUCTION 
Chronic illness is associated with unemployment leading to economic insecurity, as well as 
social isolation (Bartley & Plewis 2002, Bambra et al. 2004,). Long-term absences, inability to 
perform, loss of productivity, stigmatization, unpredictability of the disease, medications, and 
cognitive symptoms all contribute to unemployment in those with chronic illness (Linn et al. 
1985, Braveman et al. 2006). HIV/AIDS (human immunodeficiency virus)/(acquired immune 
deficiency syndrome) is not impervious to these issues. HIV/AIDS made its medical appearance 
in the 1980s, setting the scene for over a decade of public confusion and the scientific 
community racing against the clock to find a cause and a solution. The debilitating effects of 
HIV/AIDS include rapidly declining health status, quality of life, and a significantly abbreviated 
lifespan. Not until the development of the first protease inhibitor, Saquinavir, the fatal prognosis 
of HIV improved to a manageable chronic disease. As life expectancy for HIV+ individuals 
lengthens with treatment, other issues, such as sustaining employment have become apparent. 
With the vast majority of HIV+ persons being adults of working age, unemployment and job 
loss due to HIV construct serious public health and economic concerns (Yelin et al. 1991; 
Braveman et al. 2006; Kaiser Family Foundation 2007). 
 
A vast array of literature has examined the barriers for HIV+ persons in returning to work and 
the needs of HIV+ individuals in sustaining employment. However, research has implemented 
very few employment related interventions within the HIV/AIDS community. The current 
research evidence base focuses primarily on antiretroviral therapy (ART) as means of restoring 
the functioning of an individual. However, as the needs of the HIV+ person in returning to work 
(RTW) are not solely medication related, other interventions to support employment are also 
necessary. 
 
The following thesis will discuss HIV/AIDS, employment, and access the current evidence 
regarding interventions to improve employment outcomes for persons living with HIV (PLWH) 
using a Cochrane Systematic Review.    
2 LITERATURE REVIEW 
2.1 HIV/AIDS 
UNAIDS reports more than 78 million persons have been infected with HIV in the past three 
decades (UNAIDS 2014). As of 2013, the WHO reports that currently 35 million people are 
living with HIV worldwide. Globally, 0.8% of adults aged 15-49 are infected with HIV. Of 
those adults, 16 million are women. In the past three and half decades, over 39 million 
HIV/AIDS related deaths have occurred. Sub-Saharan Africa remains the highest impacted 
region of the world with 1 in every 20 adults living HIV of which, 59% are women (UNAIDS 
2014, WHO 2014).  
When a HIV+ person’s CD4 count falls below 200 cells per cubic millimeter of blood (200 
cells/mm3), clinically, the disease has progressed to AIDS. A normal CD4 counts ranges 
between 500 and 1,600 cells/mm3. An AIDS diagnosis can also be made if the patient develops 
one or more opportunistic illnesses, regardless of CD4 count. Survival, without treatment for 
HIV/AIDS, is approximately 3 years. (CDC 2015) 
 
2.2 Ramifications of the Disease 
The UNAIDS Gap Report discusses four key components widening the gap between people 
living with HIV and people without HIV: 1) Human rights violations, stigmatization and 
discrimination, 2) Access to treatment and services, 3) Gender-based inequalities, 4) 
Criminalization and exclusion. The People Living with HIV Stigma Index reports that persons 
who are HIV + as well as belong to certain populations encounter compounded stigmatization 
and discrimination for their gender, sexual orientation, participation in sex work or drug use 
(The People Living with HIV Stigma Index 2014). 
2.3 Employment 
Current HIV literature indicates unemployment and job loss is correlated with HIV infection in 
individuals of working age, especially for women (Dray-Spira et al. 2006). HIV, similar to other 
chronic illnesses, also gives rise to diminished productivity, increased absenteeism from work, 
 9 
escalated financial burden on employers, increased unemployment and loss of wages (Feeley et 
al. 2004, Fox et al. 2004, Sendi et al. 2004, Kaiser Family Foundation 2007). In the last decade, 
however, as modern treatment advances management of the disease, it is now possible for HIV+ 
persons to have a longer life expectancy and healthier lives, pushing employment retention and 
return to work (RTW) to the forefront of the HIV discussion. 
UNAIDS published unemployment averages of 37.7% for HIV+ individuals, which is more than 
three times higher than the international average unemployment rate of 11.7%. Reasons reported 
for unemployment include stigma, discrimination, restrictive policies and practices and ill 
health. One in nine people living with HIV are denied employment due to their HIV positive 
status (UNAIDS 2014). In a study conducted by van Gorp et al. of 98 HIV+ persons, who were 
actively seeking employment, only 24% of participants had returned to part or full-time work 
within two years (van Gorp et al. 1999). Rabkin et al. noted a high level of interest in returning 
to work for PLWH, however, current evidence supports relatively few actually return to work. 
The longitudinal study reported multiple factors, which supports the need for RTW interventions 
for PLWH. The authors describe work as source of income, self-esteem, companionship, and 
satisfaction. Furthermore, returning to work can serve as a ‘normalizing function’, which helps 
to eliminate the patient identity (Rabkin et al. 2004). A study by Waddell and Burton (2006) 
and a systematic review (Rueda et al. 2012), have both documented the benefits of employment 
on the health and well-being working aged adults. Blalock et al. showed that employment in 
PLWH had a positive association with self-esteem, confidence and dignity, leading to an overall 
improvement in quality of life (Blalock et al. 2002). Linn et al. cited employment as having 
multifactorial benefits, beyond a solution to financial needs, which included the satisfaction of 
creative urges, and offered an opportunity for the development of self-awareness and amassing 
achievements, which could boost self-esteem. (Linn et al. 1985) 
2.3.1 Needs 
Extensive literature recognizes key needs in returning to work for HIV+ persons. In a 2006 
comprehensive review of the literature on HIV/AIDS and return to work (RTW), Braveman and 
colleagues composed a summary of the most commonly identified needs for HIV+ person to 
return to work and maintain employment: 
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1. Mental health and emotional needs 
2. Physical and other health needs 
3. Identity needs 
4. Financial needs 
5. Training and educational needs 
Braveman’s review also notes that current literature predominately focuses on HIV+ persons 
who are unemployed (Braveman et al. 2006). However, one study, (Timmons et al. 2004) 
examined the specific needs of HIV+ persons who are employed. Assistance in identifying and 
negotiating job accommodations was pinpointed by Timmons et al. as the principal need for 
employed HIV+ individuals to maintain employment.  
 
In regards to mental health and emotional needs, repeated absenteeism or long-term absence 
from work proceeds to job loss and may result in financial instability, social isolation, and 
depression (Linn et al. 1985, Henderson et al. 2005). Linn and colleagues elaborate that the 
negative ramifications of unemployment may produce anxiety, depression, deteriorate self-
esteem and generate negative physical health effects. The effect of these consequences on 
healthy individuals can be extensive, and are even further magnified in the sick population. Linn 
and colleagues explored psychological and physical health variables after job loss. Their 
findings showed that people who made more visits to their physicians, those who spent more 
time in bed and those who took more medications experienced greater somatization, depression, 
and decreased locus of control. All of which would be potentially increased for a HIV+ persons. 
(Linn 1985) 
As unemployment effects mental health, HIV also displays a correlation to mental health status 
for HIV+ persons. In turn, mental health plays a role in determining employment, creating a 
cycle of unemployment. An Australian study identified suicidal ideation as a negative mental 
health variable related to HIV+ status in men (Kelly et al. 1998). The same study also linked 
unemployment to poor memory performance (Kelly et al. 1998, Rabkin et al. 2004). Research 
also highlights that HIV+ persons commonly suffer from fear of discrimination and 
stigmatization (Braveman 2003, Timmons et al. 2004, Braveman et al. 2006).  
2.3.2 Barriers to Employment 
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When the aforementioned needs go unmet, barriers to employment are built. After diagnosis of 
HIV, RTW can be an extensive and arduous process, especially if the HIV+ person has been 
absent from work for extended intervals (Gorman et al. 2009). HIV literature pinpoints multiple 
dynamics, which act as barriers to RTW for HIV+ persons. Barriers include health concerns 
such as unpredictability of the disease, frequently associated with recurrent, prolonged periods 
of illness, resulting in physical and cognitive impairment, medication side effects, and anxiety 
surrounding loss of disability allowance following RTW (Braveman et al. 2006; Gorman et al. 
2009).  Additionally, patient’s fear of discrimination and stigmatization at the workplace, 
following disclosure of HIV/AIDS status, acts a as barrier to RTW, especially in seeking 
accommodations, which would likely improve the sustainability of employment. (Rabkin et al. 
2004, Rao et al. 2008, Rodger et al. 2010). 
Six barriers to return to work were also identified by Braveman’s comprehensive review 
(Braveman et al. 2006): 
1. Health concerns 
2. Fear of loss of public benefits 
3. Employability and career development 
4. Stigmatization 
5. External perceptions and the ‘sick role’ 
Braveman et al. summarized health concerns into three predominant barriers: uncertainty of 
disease progression, cognitive/physical symptoms, and medications/scheduling (Braveman et 
al. 2006). Physical and cognitive symptoms may include side effects of opportunistic infections, 
as well as chronic symptoms such as fatigue, diarrhea, and wasting (Vitry-Henry et al. 1999, 
Rabkin et al. 2004). 
Fears about RTW include anticipated stigmatization and discrimination, loss of benefits, and a 
lack of belief in one’s ability to perform. The impact of the loss of benefits is contextual and 
dependent upon the residency of the HIV+ persons, yet has been noted in at least 6 different 
studies. According to Braveman, beyond the fear of loss of benefits, HIV+ persons are 
concerned about the availability of HIV medications and services, which may not be covered 
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by their new employer’s medical plans. The potential loss of access deters HIV+ persons from 
re-entering the workforce (Braveman et al. 2006). 
 
The vast number of ramifications due to HIV generates questions in the HIV discussion, such 
as “should an HIV+ person work?” Research shows a strongly divided answer to this question 
due to external perceptions and the belief in the ‘sick role’. Conyers (2004) documented that 
HIV+ persons receive external pressure from family members, social and medical providers, 
and the community to relinquish employment or to not seek re-employment after illness related 
job loss. The ‘sick role’ defines the HIV+ person as a compliant, passive medical object of care 
(De Moor et al. 2005).  
2.3.3 Employer Costs 
An important aspect in the HIV/AIDS discussion is not only whether an HIV+ person should 
return to work, but what are the employer cost of retaining HIV+ employees? A study conducted 
in South Africa and Botswana by Rosen and colleagues (2004) examined the costs of AIDS for 
businesses. The researchers constructed a four-part description of costs including direct, 
indirect, individual and organizational costs. The extensive list of direct costs include benefit 
payments, medical care, recruitment and training of a replacement worker, insurance premiums, 
accidents due to ill and inexperienced workers, and litigation over benefits. Indirectly, 
companies incur costs from reduced on the job productivity, increased absenteeism, supervisor’s 
time, vacancy, lower productivity during replacement’s start-up period, senior management 
time, production disruptions, loss of workforce morale, loss of experience and institutional 
memory, reduced returns to training investments, and deteriorating labor relations. (Rosen et al. 
2004) A Ugandan study of two companies showed that HIV/AIDS employees received 120% 
and 185% of the annual pay/benefits for the average workers (Feely et al. 2004). Due to the high 
cost of HIV/AIDS on employers, it is advantageous for employers to be actively involved in 
interventions for improving employee health and employment outcomes. Feely et al. 
demonstrates this point by noting that a year of ART costs approximately 29,000 shillings per 
person, which is only 2-4.8% of the cost lost per worker. It may follow, that if a company 
provides ART for their HIV+ employees then, health will improve, labor productivity loss will 
be diminished and pay outs for benefits, retirement and death with be reduced.  Rosen & Feely 
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highlight the need for further exploration of employer involvement in return to work 
interventions.  
2.3.4 Interventions and Studies on Return to Work 
The typical employment services offered by current HIV/AIDS service organizations are 
limited. Services usually include fact sheets pertaining to disability laws, help in preparing a 
resume, the benefits of returning to work. The aforementioned services do not adequately 
abolish the barriers present in returning to work for HIV+ persons (Kielhofner et al. 2004). 
Therefore, further employment interventions targeted at meeting the needs of HIV+ workers are 
necessary. Interventions that promote RTW for any sick person usually include all activities 
introduced to enhance the work capacity of the individual. These activities may include 
interventions directed at the employee, employer and the workplace. 
Researchers have explored numerous interventions in hopes of sustaining employment in HIV+ 
persons. Kielhofner and colleagues (2004) conducted a three-year, psycho-educational and 
occupational therapy RTW program for HIV+ persons with a participatory research strategy. 
The authors surmised that a combination method such as this, addressed a comprehensive range 
of physical, psychosocial and environmental issues. The four phase vocational program, 
Employment Options, recruited 129 participants with 30% attrition due mainly to illness, 
unrealistic vocational goals, death, and substance abuse. Phase one focused on self-assessment, 
exploration of vocational choices, pertinent job skill development, and emotional support for 
returning to work. This consisted of weekly group sessions, which taught self-assessment, 
vocational planning, job skills, job searching strategies, tools for coping in the work place, 
disability benefits, and the economic impact of RTW. Furthermore, participants received 
individual therapy and occupational coaching. Phase two aimed to build confidence in one’s 
ability to manage a work routine through to taking part in volunteer positions, internships, and 
temporary work placement. Phase three concentrated on permanent work placement and 
successful return to employment. Additionally, phase three assisted participants in seeking 
reasonable work place accommodations, as well as providing employer education. The fourth 
and final phase focused on sustaining employment and long-term follow-up including group 
meetings and staff contact. At the end of the program, 60 participants had returned to work, 
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gained new employment, went back to school, or began an internship or volunteer position. The 
study reports history of mental illness as a strong indicator whether or not an individual will be 
successful in returning to work. In light of the correlation between history of mental illness and 
successful employment, Kielhofner and colleagues highlight the importance of narrative 
understanding in order to create successful return to work interventions. Another community 
based participatory research program was the Helping Overcome Problems Effectively (HOPE) 
intervention, which focused on employment and mental health in African American gay men 
living with HIV/AIDS. The participants were male, African American, identified as 
homosexual, 18 years of age or older, unemployed, and fluent in English. The pilot program 
included 7 participants attending 7 weekly 3-hour group sessions. Topics included 
understanding HIV/AIDS, working with medications, working with health care providers, HIV 
tests and treatments, lifestyle management, employment, and further job skills development. 
The researchers found better overall mental health and increased self-efficacy in job-seeking 
skills as at 3 months post intervention 3 men were actively seeking employment, 3 were enrolled 
in college courses, and 1 was employed part-time. Participants identified problem solving and 
goal setting as two key benefits of the HOPE intervention program. Participants also identified 
mock job interviews, resume assistance, career interests assessments, and peer support buddies 
as crucial elements of the intervention. (Hergenrather et al. 2013). 
Numerous qualitative studies have examined different types of vocational and psychosocial 
rehabilitation interventions for optimizing return to work in HIV+ persons. Overall, the results 
have been positive. One vocational services intervention study targeted at HIV+ persons 
reported a positive impact on employment (Conyers 2004). The Matrix Research Institute (MRI) 
implemented the Kirk Employment Empowerment Project (KEEP) as a multi-dimensional 
intervention service approach program. KEEP services included job search assistance, disability 
management education, benefits and legal counseling, on-site job support, job related problem 
solving and skills training, referrals to and coordination with other service providers. The study 
concluded the vocational rehabilitation services improved employment outcomes for HIV+ 
persons (Escovitz & Donegan 2005). Additionally, a group counseling intervention aimed at 
boosting RTW in HIV+ persons reported a positive impact (Kohlenberg et al. 2003). Kohlenberg 
et al. researched a group counseling intervention to support RTW in HIV+ persons experiencing 
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physical and cognitive symptoms. The intervention predominately focused on the development 
of personal skills training and career plans. 
Beyond behavioral and psychological interventions studies, interventions primarily concentrate 
on Antiretroviral Therapy (ART) in sustaining employment and workforce re-entry. Previous 
pharmacological interventions studies support the use of ART in improving employment related 
economic productivity for HIV+ persons (Bernell et al. 2005, Van der Borght et al. 2006, Van 
der Borght et al. 2010). 
2.3.5 ART 
The creation of Antiretroviral Therapy (ART) produced positive results for HIV patients 
including reduced mortality, improved immune function, declining viral load burdens, 
abbreviated symptoms, and overall enhanced quality of life (Martin et al. 2005).  
The Gap Report: People Living with AIDS published by UNAIDS states that only 38% or two 
out every five of the people infected with HIV, receive ART therapy. (UNAIDS 2014) A 
systematic review on economic and quality of life outcomes for ART in developing countries 
conducted by Beard et al. consisted of 21 quantitative and qualitative publications. The 
systematic review concluded that HIV+ persons on ART reported significant improvements in 
physical, emotional, and mental health resulting in better daily function. The review found that 
compared to HIV+ who were not yet on ART, ART patients had decreased absenteeism and 
enhanced work performance. Furthermore, the review concluded that in all cohorts analyzed, 
ART was associated with a reduction in dementia, anxiety, and depression. (Beard et al. 2009) 
Interestingly, the study notes that the mere qualification for ART treatment improved the 
individual’s self-perception of physical health and emotional well-being. Booysen et al. reported 
that after less than 1 month 77% of patients on ART indicated an overall health improvement 
(Booysen et al. 2007).  The economic benefits of strongly support ART as an intervention. A 
study by Resch et al. reported a net economic benefit of $19 billion USD. The $34.2 billion 
USD gross, equals 240% of program costs for the Global Fund to Fight AIDS, Tuberculosis and 
Malaria which provides ART in low and middle income countries (Resch et al. 2011). The study 
reports that the mass delivery of ART through the Global Fund restores labor productivity in 
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workers with HIV/AIDS, reduces orphan care expenditures, and delays end of life costs 
associated with AIDS related deaths.  
2.3.6 International Legislation/ Interventions 
International interest groups and organizations have amassed substantial progress in eradicating 
workplace barriers associated with RTW for HIV+ persons. The International Labour 
Organisation (ILO), published the 'Recommendations concerning HIV and AIDS and the World 
of Work', (ILO 2010) and the 'Code of Practice on HIV/AIDS and the World of Work' (ILO 
2001). Both documents set out recommendations and good practice for the workplace, which 
include employment principles such as: non-discrimination, promotion of retention in work of 
HIV+ PERSONS, respect for the human right and dignity, universal access to preventive 
measures, treatment, and support. The ILO’s two sets of guidelines are intended to form the 
foundation for policy development to respond to HIV in the workplace (ILO 2001; ILO 2010). 
2.4 Why it is important to do this review?   
The availability of up-to-date, evidence-based employment interventions for HIV+ persons, 
goes hand in hand with employer/employee co-operation, in order to sustain employment and 
promote RTW. Reviews of RTW interventions after chronic conditions, i.e. cancer (De Boer et 
al. 2011) and musculoskeletal disorders (Schaafsma et al. 2010) are present in literature. 
However, no systematic review has been conducted aimed at assessing interventions to promote 
RTW or employment retention for HIV+ persons, specifically. 
3 MAIN OBJECTIVE 
To carry out a Cochrane Systematic Review of all current research on interventions used to help 
HIV+ persons return to work, maintain employment and prevent job loss. Thereby, highlighting 
the most effective methods, which have been employed to improve job retention and shorten 
RTW times for HIV+ persons. The results from this review can then be utilized in work place 
policies, government & non-profit initiatives and within communities to improve the economic 
viability of individuals diagnosed as HIV+.   
4 METHODS 
4.1 Criteria for considering studies for this review   
4.1.1 Types of studies   
We assessed all eligible randomized controlled trials (RCTs) for inclusion in this review. 
However, due to the complexity of conducting RCTs in work organizations, we also accepted 
cluster RCTs and controlled before-after (CBA) studies.  
4.1.2 Types of participants   
We included studies conducted with HIV+ persons aged 16 years and over who were employed 
or unemployed at the time of diagnosis, irrespective of the stage of disease at the time of 
diagnosis.  
4.1.3 Types of interventions   
We included studies that evaluated any intervention or arrangement aimed at sustaining work 
or employment in people living with HIV. We considered interventions that were targeted at the 
workplace or at the individual or groups of individuals within the workplace or community, 
including policies aimed at preserving employment in specific categories of workers. We 
categorized interventions as follows:  
 Medical or pharmacological interventions such as provision of free ART or 
antidepressants.  
  Vocational interventions such as vocational or occupational rehabilitation, workplace 
adjustments such as protected time for medication, change in work schedule or duties, 
modified work hours, or improved communication with or between managers, 
colleagues, and health professionals.  
 Psychological interventions such as education, counseling, cognitive-behavioral 
interventions, training in coping skills, or group psychotherapy.  
 A combination of any of the above.  
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4.1.4 Types of outcome measures   
4.1.4.1 Primary outcomes   
 RTW, measured either as the number of days to partial or full work resumption or as the number 
of days absent during follow-up.  
 Job loss, measured as the number of people who lost their job during the time of follow-up. As 
the complement of job loss is being employed, we also included studies that had measured being 
employed or the amount of time spent at work.  
4.1.4.2 Secondary outcomes   
 Overall quality of life (physical and emotional).  
 Cost of intervention programs and cost effectiveness of RTW or employment.  
4.2 Search methods for identification of studies   
4.2.1 Electronic searches   
We searched for relevant studies in the following databases:  
• Cochrane Central Register of Controlled Trials (CENTRAL; 2014, Issue 12)   
• MEDLINE (1980 to December 2014)  
• EMBASE (1980 to December 2014)  
• CINAHL (1983 to December 2014)  
• OSH UPDATE databases (CISDOC, HSELINE, NIOSHTIC, NIOSHTIC-2, RILOSH; 
1980 to December 2014)  
• PsycINFO (1980 December 2014)  
We have presented the search strategies for MEDLINE, CENTRAL, EMBASE, and OSH 
UPDATE as Appendix 3. We designed the strategies to include appropriate MeSH subject 
headings and text word terms, interventions under consideration, and included study designs. 
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We restricted the searches to years from 1981 onwards, reflecting the year when the first 
acquired immunodeficiency syndrome (AIDS) cases were reported in the United States. We 
imposed no language restrictions.  
4.2.2 Searching other resources   
We screened the reference lists of selected articles and reviews to locate additional potentially 
eligible studies.  We considered articles and studies published in any language. We intended 
for relevant articles published in languages other than English to be translated, but we found no 
such articles. When we required further information to determine inclusion, we wrote to the 
corresponding authors.  
4.3 Data collection and analysis   
4.3.1 Selection of studies   
We carried out the selection of eligible studies in two stages. 
Stage 1: Three review authors [Rachel Robinson (RR), Emmanuel Okpo (EO), and Nomusa 
Mngoma (NM)] independently screened the titles and abstracts of studies the search strategy 
identified for relevance, that is whether the study assessed the effectiveness of an intervention 
aimed at sustaining employment in HIV- infected individuals and measured RTW. If the title 
and abstract provided sufficient information to determine that the study did not satisfy the 
criteria for inclusion, we excluded the study. Review authors resolved differences in opinion 
through discussion.  
Stage 2: We retrieved full texts of all the studies selected in stage 1. Each review author then 
independently examined whether the selected studies met the inclusion criteria. At this stage, 
we documented the reasons for study exclusion. We resolved differences in opinion by 
discussion and consensus.  
We have presented a PRISMA study flow diagram to describe the sequence of steps in the 
screening process and reasons for the exclusion of studies in Figure 1.  
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4.3.2 Data extraction and management   
We designed a data extraction form specifically for this review that captured key elements such 
as study design, country, setting, socio-demographic characteristics of participants including 
ethnicity, interventions (content, duration, provider, context), follow- up, and all outcomes of 
interest, particularly RTW measures. Review authors (RR, EO, and NM) independently 
extracted data from the eligible studies.  
4.3.3 Assessment of risk of bias in included studies   
All three review authors (RR, EO, and NM) independently assessed the risk of bias of all the 
included studies by following the procedures described in the Cochrane Handbook for 
Systematic Reviews of Interventions (Higgins & Green 2011). We assessed RCTs and cluster 
RCTs against the six domains listed below. We rated studies as having ’low risk of bias’ 
(plausible bias unlikely to seriously alter the results); ’high risk of bias’ (plausible bias that 
seriously weakens confidence in the results); or ’unclear risk of bias’ (plausible bias that raises 
some doubt about results).  
• Sequence generation: Was the allocation sequence adequately described?  
• Allocation concealment: Was allocation adequately concealed?  
• Blinding of participants, personnel, and outcome assessors: Was knowledge of the allocation 
intervention adequately prevented during the study?  
• Incomplete outcome data: Was incomplete outcome data adequately addressed?  
• Selective outcome reporting: Are reports of the study free of suggestion of selective outcome 
reporting?  
• Other sources of bias: Did the study appear to be free of other problems that could put it at 
high risk of bias?  
For non-randomized studies, we utilized the checklist developed by Downs and Black (1998) to 
measure the quality of the studies. The criteria consist of several scales, but our review team 
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used only the following two:  
• Internal validity in terms of bias (seven items)  
• Internal validity in terms of confounding and selection bias (six items)  
We added an additional item on baseline comparability of intervention and control group, but 
we did not use the item on power of the study. We combined all items with the Cochrane ‘Risk 
of bias’ tool in the Characteristics of included studies section. For confounding and baseline 
comparability, we used the following factors that according to our judgment could increase or 
decrease employment: gender, age, socioeconomic status, migration status, disease severity.  
Instead of the original score as ‘yes’, ‘no’, or ‘unable to determine’, we used ‘low’, ‘high’, and 
‘unclear’ risk of bias to make the checklist compatible with the Cochrane ‘Risk of bias’ tool as 
implemented in RevMan (2014).  
We determined blinding of participants to be ‘low risk’ for retrospective studies because 
participants were unaware of the intervention at the time. Conversely, we considered blinding 
of participants to be ‘high risk’ if study authors did not report having used blinding or if it was 
clear from the report that the study was unblinded. See point 14 in our ’Risk of bias’ assessments 
in the Characteristics of included studies section.  
4.3.4 Measures of treatment effect   
We plotted the results of each study as point estimates. For binary outcomes, that is where the 
probability of an event occurring or not occurring is considered, we used risk ratios RRs as the 
measure of effect; if this was not reported, we used odds ratios ORs. For continuous outcomes, 
we plotted the results of individual studies using mean differences MDs. The reporting of effect 
sizes did not require the use of standardized mean difference as we found no studies using 
similar continuous outcome measures. When we could not plot the results, we described them 
in the text.  
4.3.5 Unit of analysis issues   
As we found no cluster RCTs to include in the review, we did not have to contend with unit of 
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analysis problems.  If in future updates we encounter studies that employ a cluster- randomized 
design and that report sufficient data for us to include in the meta-analysis but do not make an 
allowance for the design effect, we will calculate the design effect based on a fairly large 
assumed intra-cluster correlation of 0.10. We based this assumption of 0.10 being a realistic 
estimate by analogy on studies about implementation research (Campbell et al. 2001). We will 
follow the methods stated in the Cochrane Handbook for Systematic Reviews of Interventions 
for the calculations (Higgins & Green 2011).  
If in future updates we find studies with repeat observations on participants, we will compute 
an effect measure for each participant factoring in all the time points and will present this as 
trends over time or overall means, depending on the data.  
4.3.6 Dealing with missing data   
When the issue of missing data arose, we discussed the reasons why the data could be missing 
and determined a way of dealing with it accordingly. Where we suspected missing data due to 
a lack of publication, publication in obscure places, or data presented inappropriately, we did 
whatever was possible to contact the original authors of the studies.  
  
If in future updates of this review we discover that participants are missing from the reported 
results, such as when analyses of randomized trials do not include all randomized participants 
(not intention-to-treat analyses), we will consider performing intention-to-treat analysis on the 
presented data. We will also consider:  
• analyzing only the available data (i.e. ignoring the missing data);  
• imputing the missing data with replacement values and treating these as if they were 
observed;  
• imputing the missing data and accounting for the fact that these were imputed with 
uncertainty;  
• using statistical models to allow for missing data while making assumptions about their 
 24 
relationships with the available data.  
We explicitly state the assumptions of any methods used to cope with missing data and perform 
sensitivity analyses to assess how sensitive results are to changes in the assumptions.  
4.3.7 Assessment of heterogeneity   
We assessed clinical homogeneity based on similarity of the population, intervention, outcome, 
and follow-up. We considered populations as similar when they were people living with HIV 
aged 16 years and over irrespective of the stage of the disease at the time of diagnosis. We 
considered the various intervention categories (as outlined in Types of interventions) as 
different. We deemed the various outcome categories as different. For the RTW outcome, both 
the number of days to partial or full work resumption and number of days absent during follow-
up had to be sufficiently similar to combine them as similar outcomes. We regarded follow- up 
times as different if they were less than three months, three months to one year, and more than 
one year.  
In conducting meta-analyses, we considered the extent to which the results of studies are 
consistent by comparing confidence intervals for the results of individual studies and observing 
overlap as indication of the presence of statistical heterogeneity. We performed a Chi2 test to 
further check for statistical heterogeneity. When the P value indicated that there was 
heterogeneity, we used the result of the I2 measure to quantify the degree of heterogeneity. A 
percentage of 0% to 40% indicated that heterogeneity might not be important; 30% to 60% 
signified moderate heterogeneity; 50% to 90% substantial heterogeneity; and 75% to 100% 
considerable heterogeneity.  
4.3.8 Assessment of reporting biases   
We compared the outcomes listed in the methods section of an article with the reported results. 
We considered inadequately reported, non-significant results as a potential source of bias. We 
included published and unpublished data on the intervention under review to reduce publication 
bias. If sufficient data are available in future updates of this review, we will use funnel plots to 
detect reporting bias. We reduced the effect of reporting bias by including studies and not 
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publications in order to avoid the introduction of duplicated data (that is two articles could 
represent duplicate publications of the same study). Following the Cho (2000) statement on 
redundant publications, we extracted data only once for duplicate studies or if multiple articles 
reported on the same study. We prevented location bias by searching across multiple databases. 
Additionally, we prevented language bias by not excluding any article based on language.  
4.3.9 Data synthesis   
As this review includes different types of studies (randomized and non-randomized studies), we 
analyzed the data separately for the different study designs. We pooled suitably homogeneous 
data using Review Manager 5.3 software (RevMan 2014). The meta-analyses is presented in the 
Summary of findings for the main comparison.  
When sufficient data was available, we performed meta-analyses for two studies. As the studies 
were statistically homogeneous, we used a fixed-effect model. We included 95% confidence 
interval (CI) for all estimates. In future updates of the review, if studies are heterogeneous, we 
will use a random-effects model. When using the random-effects model, we will conduct a 
sensitivity check by using the fixed-effect model to reveal differences in results.  
We assessed the quality of evidence using the GRADE approach as described in the Cochrane 
Handbook for Systematic Reviews of Interventions (Higgins & Green 2011). See Appendix 
2.  We downgraded the quality of evidence for the RTW outcome based on the following 
factors:  
• Limitations of the study design and implementation: allocation concealment, blinding, 
loss to follow-up, and selective reporting  
• Indirectness of evidence: indirect population, intervention, control, and outcomes  
• Inconsistency of results: subgroup analysis, heterogeneity, and inconsistent results  
• Imprecision of results: wide confidence intervals  
• Publication bias  
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We considered upgrading the quality of evidence for CBA studies based on the following 
factors:  
• Magnitude of the effect 
• Dose-effect relation   
• All confounding excluded  
The GRADE approach specifies four levels of quality (high, moderate, low, and very low).  
4.3.10 Subgroup analysis and investigation of heterogeneity   
Although we had planned to carry out a series of subgroup analyses, the included studies did 
not provide sufficient data to do so. In future updates, wherever possible, we will carry out 
subgroup analysis to account for differences in the primary outcome of RTW and disability rates 
between: 
 gender, i.e. men versus women; 
 different stages of the disease, e.g. clinically asymptomatic (WHO stages 1 and 2) versus 
symptomatic including AIDS (WHO stages 3 and 4); 
 type of employment before diagnosis was made, e.g. health-related versus non-health-
related employment; 
 economic setting, e.g. low income, lower middle income, and upper middle income 
versus high income. 
If we can conduct meta-analyses in future updates, we will quantify the degree of heterogeneity 
using the I² statistic, where an I² value of 30% to 60% indicates moderate heterogeneity, 50% to 
90% substantial heterogeneity, and greater than 75% considerable heterogeneity (Higgins & 
Green 2011). We will investigate substantial heterogeneity further using meta–regression 
assuming that we have included an adequate number of studies. 
4.3.11 Sensitivity analysis   
In our protocol we planned to conduct a sensitivity analysis to monitor the robustness of the 
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results. However, our meta-analysis only includes two studies. Therefore, we did not conduct a 
sensitivity analysis.  
5 RESULTS  
5.1 Results of the search   
We searched six key databases up to December 2014: the Cochrane Central Register of 
Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, PsycINFO, and OSH Update 
(CISDOC, HSELINE, NIOSHTIC, NIOSHTIC 2, RILOSH). The initial search in 2012 yielded 
a total of 5799 studies. After removal of duplicate references, 4787 studies remained. In June 
2013 and December 2014 we conducted updated searches of all aforementioned databases, 
resulting in an additional 460 and 331 references, respectively. We obtained a combined total 
of 5578 references for title and abstract inspection.  
Evaluation of the reference titles and abstracts identified 29 studies for full-text examination. 
Nine studies did not meet the study de- sign criteria of RCT or CBA studies. We disqualified 
two studies due to topic irrelevance. We excluded an additional five studies due to lack of a 
control group. We eliminated one final study that focused on chronic diseases and RTW because 
HIV-specific out- come data was unavailable (we requested raw data from the authors but they 
could not provide HIV-specific data). Ten studies remained for further consideration (Paul-
Ward et al. 2005, Borwein et al. 2010, Popiel 2010, Thirumurthy et al. 2011, Bor et al. 2012, 
Baran 2012, Martin et al. 2012, Larson et al. 2013, Linnemayr et al. 2013, Nannungi et al. 2013). 
We categorized four of these as ’Studies awaiting classification’ (see Characteristics of studies 
awaiting classification); three due to a lack of full-text article and one because it was in progress 
in 2005, but we could not locate a final publication of outcome data. We requested full-text 
articles from the authors of these studies as well as unpublished raw outcome data, but we 
received none. The remaining six studies (one RCT and five CBA studies) formed the list of the 
final six included studies on which we performed data extraction and ’Risk of bias’ assessment 
(Thirumurthy et al. 2011, Bor et al. 2012, Martin et al. 2012, Larson et al. 2013, Linnemayr et 
al. 2013, Nannungi et al. 2013). For the search flow diagram, see Figure 1.  
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5.1.1. Included studies   
Figure 1. PRISMA study flow diagram 
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See Characteristics of included studies. (Appendix 1A) 
5.1.1.1 Study designs 
We found one RCT (Martin et al. 2012) and five CBA studies (Thirumurthy et al. 2011, Bor et 
al. 2012, Larson et al. 2013, Linnemayr et al. 2013, Nannungi et al. 2013). The RCT utilized a 
stratified randomization procedure; the researchers stratified participants of both control and 
index groups on education, CD4 count, and ethnic minority status to account for potential 
influence of these covariates. All five CBA studies were ART studies (Thirumurthy et al. 2011, 
Bor et al. 2012, Larson et al. 2013, Linnemayr et al. 2013, Nannungi et al. 2013). Both Larson 
et al. 2013 and Bor et al. 2012 were retrospective analyses of cohorts. Linnemayr et al. 2013, 
Nannungi et al. 2013, and Thirumurthy et al. 2011 were prospective cohort studies.  
5.1.1.2 Number of participants 
Martin et al. 2012 studied 174 HIV+ persons, comprised of 83 index participants and 91 
references. Bor et al. 2012, Larson et al. 2013, Linnemayr et al. 2013, Nannungi et al. 2013, and 
Thirumurthy et al. 2011 studied a total of 3336 index participants and 44,722 references.  
5.1.1.3 Types of participants 
The vocational therapy RCT conducted by Martin et al. 2012 recruited participants through 
advertisements at AIDS service organizations, community and mental health centers, HIV 
medical providers, gay and lesbian centers, community forums for HIV+ adults, and through 
advertisements in publications targeted at HIV+ persons in the United States.  
Two studies analyzed HIV+ workers referenced against the non- HIV general work force (Bor 
et al. 2012, Larson et al. 2013). Larson et al. 2013 examined a cohort of tea pluckers in two 
major Kenyan tea plantations. Bor et al. 2012 used data from all inhabitants of Hlabisa sub- 
district in South Africa and combined employment data extracted from the Africa Centre for 
Health and Population Studies surveil- lance system with data on being HIV+ from the Hlabisa 
HIV Treatment and Care Program records.  
Three studies compared HIV+ persons on ART to HIV+ persons not yet eligible for ART 
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(Thirumurthy et al. 2011, Linnemayr et al. 2013, Nannungi et al. 2013). Linnemayr et al. 2013 
and Nannungi et al. 2013 examined participants from four Ugandan HIV treatment clinics, one 
rural (Kakira) and three urban (Kampala). Thirumurthy et al. 2011 compared HIV+ persons who 
had initiated ART with HIV+ persons who were classified as pre-ART and were a part of the 
Tamil Nadu Family Care Continuum (TNFCC) Program in Tamil Nadu, India. In all five CBA 
studies, participants were of working age (16 years or older) and were HIV+. Additionally, 
Thirumurthy et al. 2011 also included 67 children in their analysis as well as 54 caretakers.  
5.1.1.4 Interventions 
The included studies evaluated five pharmacological ART interventions and one mixed 
vocational and psychological intervention (Thirumurthy et al. 2011, Bor et al. 2012, Martin et 
al. 2012, Larson et al. 2013, Linnemayr et al. 2013, Nannungi et al. 2013). We found no 
psychological interventions. The vocational intervention consisted of 13 group sessions with at 
least 1 individual session, carried out over a 7 week period (Martin et al. 2012). The group 
sessions included presentations, brainstorming, discussions, role playing, and homework 
assignments regarding motivation and barriers to RTW, concerns of a HIV+ persons in the work 
force, skills for retaining a job, and “thinking like an employer” training.  
The pharmacological intervention CBAs consisted of measuring employment outcomes prior to 
ART initiation, at the time of ART initiation, and at several follow-up intervals (Thirumurthy et 
al. 2011, Bor et al. 2012, Larson et al. 2013, Linnemayr et al. 2013, Nannungi et al. 2013). HIV+ 
persons in the Larson et al. 2013 study received free ART through their workplace hospitals and 
clinics. Participants in the Bor et al. 2012 study received free ART from the Hlabisa HIV 
Treatment and Care Program. In the Linnemayr et al. 2013 study, participants received basic 
HIV primary medical care and ART from two Joint Clinical Research Centre HIV clinics in 
Uganda, one rural (Kakira) and one urban (Kampala). The participants in Nannungi et al. 2013 
acquired HIV primary medical care and ART from two HIV clinics in urban Kampala, Uganda. 
Thirumurthy et al. 2011 participants received free ART from the TNFCC Program. 
Additionally, all of the Thirumurthy et al. 2011 participants received other clinical care services, 
nutritional supplements, and home-based care, which for the indexed participants involved ART 
adherence support.  
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5.1.1.5 Time period and location 
All six included studies were conducted between 2000 and 2013. The studies were conducted 
in South Africa, the United States, India, Kenya, and Uganda.  
5.1.1.6 Outcomes reported 
RCT  
The Martin et al. 2012 study measured employment as any type of employment in the past 6 
months, job training class attendance, and active job searching in the past 30 days.  Although 
Martin et al. 2012 reported having measured employment outcomes at 6, 12, 18, and 24 months 
post-ART initiation, only baseline data was published. We requested the 6, 12, 18, and 24 month 
follow-up outcome data from the authors, but we did not receive a response.  
CBA  
Bor et al. 2012 measured employment solely as employed versus unemployed. Employment 
was measured 24, 18, 12, and 6 months before beginning ART and 0, 6, 18, 24, and 30 to 60 
months following ART initiation. The authors reported the ORs from logistic regression with 
T-values. We calculated the standard error needed for determining 95% CI by dividing the 
logOR by the reported T-value.  
Larson et al. 2013 measured employment as days worked in the past month and stratified the 
results by gender. The researchers measured employment 24, 18, 12, and 6 months before 
beginning ART and 0, 6, 18, 24, and 30 to 60 months following ART initiation.  
Linnemayr et al. 2013 measured employment status based on whether or not the HIV+ persons 
had participated in employment activity in the week prior to the interview. The researchers 
measured employment for all participants at 0, 6, and 12 months and reported as changes in 
employment status. The authors reported the ORs from logistic regression with T-values. We 
calculated the standard error needed for input into the data tables by dividing the logOR by the 
reported T-value. The authors graphically reported 0, 6, and 12 months outcomes for currently 
working, pain interference with work, health interference with work, and work self-efficacy. 
 33 
We contacted the authors for the raw data of these outcomes, however, we did not receive a 
response.  
Nannungi et al. 2013 measured employment status as a binary outcome based on whether or not 
the HIV+ persons had participated in employment activity in the week prior to the interview. 
The researchers measured employment for all participants at 0, 6, and 12 months.  
Thirumurthy et al. 2011 measured employment as hours worked in the last week and stratified 
the results by gender. The researchers measured employment at 6, 12, 18, and 24 months 
following ART initiation. We contacted the authors for further explanation of Table 3, however, 
we did not receive a response.   
None of the included studies, whether RCT or CBA, measured our secondary outcomes of 
quality of life or costs.  
5.1.2 Excluded studies   
We gave 19 studies particular consideration before exclusion as detailed in the Characteristics 
of excluded studies section. We excluded nine of these studies on the basis of irrelevant study 
design, that is they were not RCTs or CBA intervention studies (Rosolen et al. 2002, Martin et 
al. 2003, Rosen et al. 2004, Bernell & Shinogle 2005, Van der Borght 2006, Van der Borght 
2010, Resch et al. 2011, Rueda et al. 2012, Thirumurthy et al. 2013). Six studies did not have 
control groups (Goldman & Bao 2004, Escovitz & Donegan 2005, Ajithkumar et al. 2007, 
Rosen et al. 2010, Hergenrather et al. 2013, Rosen et al. 2014). We excluded one purely 
qualitative study (Maticka-Tyndale et al. 2002). We excluded Herdt et al. 1999 due to lack of 
topic relevance. We excluded Lee & Chan 2005 due to a lack of specific HIV data. We excluded 
a summary of an ongoing study that was later published in 2012 (Martin et al. 2005, Martin et 
al. 2012). (Appendix 1B) 
5.2 Risk of bias in included studies   
See Figure 2 for an overall view of our assessment of the included studies’ risk of bias.  
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  Figure 2: Risk of Bias Summary 
 5.2.1 Allocation (selection bias)   
RCT  
The researchers of the RCT reported adequate details on their randomization sequence 
generation (Martin et al. 2012). However, we judged their allocation concealment to be unclear. 
As the study recruited participants from multiple AIDS service organizations, community 
mental health centers, HIV medical providers, and gay/lesbian centers, some participant features 
may be disproportionately represented in index and reference groups. However, reported 
baseline demographics were similar between groups. We therefore determined the risk of 
population selection bias as unclear. We found no evidence of time selection bias, as recruitment 
of all participants occurred during the same time frame.  
CBA 
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Neither of the retrospective studies reported the use of adequate sequence generation (Bor et al. 
2012, Larson et al. 2013). The CBA studies did not use randomization or allocation concealment 
(Thirumurthy et al. 2011, Bor et al. 2012, Larson et al. 2013, Linnemayr et al. 2013, Nannungi 
et al. 2013). Prior analysis predetermined allocation to reference and control groups in both 
retrospective cohort studies (Bor et al. 2012, Larson et al. 2013). None of the prospective cohort 
studies reported the use of adequate sequence generation or allocation concealment 
(Thirumurthy et al. 2011, Linnemayr et al. 2013, Nannungi et al. 2013). The participants’ CD4 
counts and health status preordained allocation to index and reference groups in the prospective 
studies (Thirumurthy et al. 2011, Linnemayr et al. 2013, Nannungi et al. 2013).  All HIV+ 
persons utilizing ART (CD4 count less than 250 cells/mm3) were assigned to the index group 
and all HIV+ persons pre-ART (CD4 count less than 400 cells/mm3 but greater than 250 
cells/mm3) were assigned to the control group. We considered the risk of selection bias for the 
population as low in all five observational studies. Three studies’ use of HIV+ persons seeking 
care for both the index and reference groups reduces selection bias by eliminating the potential 
differences between people who choose to seek care and those who choose not to seek care 
(Thirumurthy et al. 2011, Linnemayr et al. 2013, Nannungi et al. 2013). Bor et al. 2012 gathered 
participants in both the index and reference groups from the Africa Center for Health and 
Population Studies’ population surveillance system. Bor et al. 2012 included all HIV+ people 
who were utilizing ART during the 10 year follow-up period of the Africa Centre for Health 
and Population Studies population surveillance study and who sought care through the Hlabsia 
HIV Treatment and Care Programme as index participants. Larson et al. 2013 collected all 
participants from the work forces of two Kenyan tea plantations. For index participants, Larson 
et al. 2013 used all HIV+ workers who visited the tea plantation hospitals and healthcare clinics. 
Linnemayr et al. 2013 used clinic staff to approach eligible clients for study participation at the 
appointment in which ART eligibility was assessed. Nannungi et al. 2013 enrolled consecutive 
new clinic clients who had recently been evaluated for ART eligibility. Thirumurthy et al. 2011 
procured index and reference group participants from the Tamil Nadu Family Care Continuum 
Program.  There was no randomization in any of the five studies, as all HIV+ persons who were 
utilizing ART were assigned to the index group out of physical necessity. However, we judged 
the studies as at low risk of selection bias, as all HIV+ persons using ART were assigned to the 
index group. Recruitment of index and reference participants occurred at the same time in all 
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five observational studies, showing no time-based selection bias.  
5.2.2 Blinding (performance bias and detection bias)   
RCT  
As Martin et al. 2012 did not report blinding of participants or outcome assessors, we assessed 
the risk of bias due to blinding as high.  
CBA  
For two of the CBA studies, due to the retrospective comparisons of HIV+ persons on ART 
versus healthy people, we considered the participants to be blind to the idea of a special 
intervention, as they were not aware of the study at the time (Bor et al. 2012, Larson et al. 2013). 
For the prospective HIV+ persons on ART versus HIV+ persons pre-ART comparison, 
Linnemayr et al. 2013, Nannungi et al. 2013, and Thirumurthy et al. 2011 did not blind 
participants, as health status required knowledge of treatment. Nevertheless, due to the objective 
employment/unemployment outcome in all five CBA studies, we believe the lack of blinding 
has not biased the results. Blinding of the outcome assessors was unclear in all five CBA studies, 
however we believe that this lack of assessor blinding did not bias results due to objective 
administrative outcomes.  
5.2.3 Incomplete outcome data (attrition bias)   
RCT  
Martin et al. 2012 did not report employment rates past the baseline and did not address attrition 
and reasons for missing data. We therefore assessed the risk of bias due to incomplete outcome 
data as high.  
CBA  
All five of the non-randomized CBAs addressed attrition rates of the index (Thirumurthy et al. 
2011, Bor et al. 2012, Larson et al. 2013, Linnemayr et al. 2013, Nannungi et al. 2013). Larson 
et al. 2013 missed data on 6% of index participants due to death, resignation, or retirement. 
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Larson et al. 2013 reported no attrition data on the control group. Bor et al. 2012 excluded data 
on 20% of index participants due to attrition, mortality, late cohort entry, and lack of 
employment information, but did not report attrition data for the reference group. Linnemayr et 
al. 2013 reported low attrition with approximately 95% retention of study participants and used 
an intention-to-treat analysis. However, Nannungi et al. 2013 reported 30% attrition at 6 months, 
which increased to 36% at 12 months. The high level of attrition in Nannungi et al. 2013 was 
evenly distributed between the ART and non-ART groups, at 37% and 35%, respectively. 
Thirumurthy et al. 2011 had an attrition of 34% and did not report any outcome data for controls.  
Due to a lack of reporting of attrition for the controls in three studies (Thirumurthy et al. 2011, 
Bor et al. 2012, Larson et al. 2013), we judged the risk of bias to be high for incomplete outcome 
data.  Two studies reported no data for compliance to ART intervention (Bor et al. 2012, Larson 
et al. 2013). Neither Linnemayr et al. 2013 nor Nannungi et al. 2013 measured compliance with 
ART. Thirumurthy et al. 2011 provided ART adherence support but did not provide data for 
compliance. However, in all five ART intervention studies (Thirumurthy et al. 2011, Bor et al. 
2012, Larson et al. 2013, Linnemayr et al. 2013, Nannungi et al. 2013), we can reasonably 
assume that compliance to ART medications would be high, as the health of the participant is 
highly dependent upon adherence. Martin et al. 2012 monitored compliance and conducted a 
dose-response analysis, but insufficiently reported the results and explanation.  
We judged all five CBA studies to have an unclear risk of bias for compliance with the 
intervention, due to a lack of reporting of compliance measures combined with the necessity of 
ART for survival, which may encourage intervention compliance.  
5.2.4 Selective reporting (reporting bias)   
We judged Martin et al. 2012 to have a high risk of reporting bias due to complete lack of 
reporting of any follow-up outcome data. All five CBA studies, Bor et al. 2012, Larson et al. 
2013, Linnemayr et al. 2013, Nannungi et al. 2013, and Thirumurthy et al. 2011, reported all of 
the original outcomes determined at the onset of the study for the index groups.  
The two retrospective observational studies conducted retrospective unplanned subgroup 
analysis (Bor et al. 2012; Larson et al. 2013), whereas the single RCT is most likely guilty of 
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data dredging due to complete lack of outcome reporting and presenting results based on 
complicated and unjustified statistical analysis (Martin et al. 2012). We determined that the three 
prospective CBA studies did not indicate any unplanned retrospective subgroup analysis 
(Thirumurthy et al. 2011, Linnemayr et al. 2013, Nannungi et al. 2013). 
5.2.5 Other potential sources of bias   
RCT  
The single RCT did not report any co-occurring interventions (Martin et al. 2012). Also, the 
authors did not account for ART utilization in the health status outcome, which could have 
influenced the results. Hence, we judged Martin et al. 2012 to have a high risk of other bias.  
CBA  
Baseline comparability assessment of the index and reference groups shows a high risk of bias 
for all five studies (Thirumurthy et al. 2011, Bor et al. 2012, Larson et al. 2013, Linnemayr et 
al. 2013, Nannungi et al. 2013). As the studies inconsistently reported baseline characteristics, 
it is unclear if the baseline characteristics were appropriately comparable within comparisons. 
The baseline characteristics of intervention participants presented in the Linnemayr et al. 2013 
study showed significantly fewer are working, higher levels of pain interfering with work, 
higher levels of health interfering with work, lower levels of self-efficacy, lower CD4 counts, 
lower levels of primary education, higher rates of depression, and lower overall physical 
function. The authors claim to have performed a sensitivity analysis restricting the control group 
to those with a similar health status as the intervention group, but for whom ART had been 
deferred. Linnemayr et al alleged that the results of the sensitivity analysis did not differ from 
the intention-to-treat analysis, meaning that the differences in health status at baseline did not 
affect the intervention effect. However, this data was not published. The Nannungi et al. 2013 
study baseline characteristics showed a higher percentage of controls working at baseline with 
better overall health. The beneficial outcome reported may be confounded by the difference in 
disease severity at baseline between the pre-ART participants and the participants initiating 
ART. The health of HIV+ persons on ART may improve over time, while pre-ART participants’ 
health may decline, leading to an inflation of the intervention effect. The Linnemayr et al. 2013 
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study avoided similar inflation of the intervention effect by performing intention-to-treat 
analysis, keeping all participants in their original groups regardless of ART status at end of 
follow-up. However, the use of intention- to-treat analysis may have undermined the overall 
effect of the intervention. Once again, Linnemayr et al claim to have performed a second 
sensitivity analysis that excluded all participants in the control group who initiated ART during 
the study period. The analysis supposedly resulted in similar findings to the intention- to-treat 
analysis, therefore the authors did not provide the data and it cannot be verified within the text.  
We assigned a high risk of bias to three of the observational CBA studies due to a lack of 
adjustment for confounding. Bor et al. 2012 adjusted for migration but did not adjust for age, 
sex, socioeconomic status, or disease severity. Larson et al. 2013 adjusted for gender but did not 
adjust for age, socioeconomic status, migration, or disease severity. Thirumurthy et al. 2011 
adjusted for gender but did not adjust for age, socioeconomic status, migration, or disease 
severity. We deemed an unclear risk of bias for two of the prospective observational studies for 
adjustment for confounding, as they adjusted for some but not all potential confounders. 
Linnemayr et al. 2013 stratified data by gender and urban/rural and included physical and mental 
health confounders. Nannungi et al. 2013 adjusted for changes in physical health status, age, 
gender, education, relationship status, and CD4 count.  
None of the five CBA studies reported possible co-interventions that may have influenced the 
employment outcome.  Due to the file drawer phenomenon, bias often results in the publication 
of only positive-outcome studies. All studies included in this review provided positive 
intervention effects, leading to a possible artificially augmented effect. However, in regards to 
the ART intervention, the well-documented improvement in health status due to ART supports 
the positive findings.  
5.2.6 Overall risk of bias in studies 
RCT  
We determined the overall risk of bias in the RCT based on allocation 
concealment/randomization, blinding, loss to follow-up, and selective reporting. We had 
decided a priori to consider studies to have a low risk of bias if all four items were graded as 
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low.  
The above criteria resulted in a judgment of high overall risk of bias for Martin et al. 2012. The 
study had an unclear risk of allocation concealment and a high risk of bias due to a lack of 
blinding and selective reporting.  
CBA  
We determined the overall risk of bias in the CBA studies based on selection bias (items 21 and 
22), adjustment for confounding (25), and baseline comparability using the Downs and Black 
(1998) checklist. We disregarded randomization and allocation concealment, as by definition 
the studies are non-randomized. We did not include blinding of outcome assessors, participants, 
and providers because the outcome is objectively obtained. We had decided a priori to consider 
a study to have a low overall risk of bias if all four items were graded as low.  
See Figure 2 for an overall view of our assessment of the included studies’ risk of bias.  Bor et 
al. 2012 had a high overall risk of bias. Study characteristics included a low risk of selection 
bias, a high risk of bias associated with adjustment for confounding, and a high risk of bias for 
base- line comparability.  
Larson et al. 2013 had a high overall risk of bias. Study characteristics included low risk of 
selection bias, a high risk of bias due to a lack of adjustment for confounding, and a high risk of 
bias for baseline comparability.  
Linnemayr et al. 2013 had a high overall risk of bias. Study characteristics included a high risk 
of population selection bias, an unclear risk of time selection bias, an unclear risk of bias for 
adjustment for confounding, and an unclear risk for baseline comparability. Nannungi et al. 
2013 had a high overall risk of bias. Study characteristics included a high risk of population 
selection bias, a low risk of time selection bias, an unclear risk of bias due to adjustments for 
confounding, and a high risk of bias for baseline comparability. Thirumurthy et al. 2011 also 
had a high overall risk of bias. Study characteristics included a low risk of selection bias, a high 
risk of bias due to adjustment for confounding, and an unclear risk of bias for baseline 
comparability.  
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See Appendix 1 for Risk of Bias assessments for individual studies.   
5.3 Effects of the interventions 
5.3.1 Pharmacological interventions 
5.3.1.1 HIV+ persons utilizing ART versus healthy (non-HIV+) individuals  
Two CBA studies compared the effect of ART interventions in HIV+ persons on employment 
status to a control group of healthy, untreated participants (Bor et al. 2012, Larson et al. 2013). 
Both studies used existing data on health and employment outcomes before and after ART 
initiation. Bor et al. 2012 used retrospective data from a cohort from the Hlabisa Treatment and 
Care Program surveillance area in South Africa over 10 years. Larson et al. 2013 drew data from 
hospitals and employer records of two major Kenyan tea plantations. The studies defined 
employment status as employed/unemployed and as the number of days worked per month. As 
an employment measure, the number of days worked highlights the ability of the participant to 
maintain work in comparison to the healthy controls.  
We could not combine the results of these studies in meta-analysis due to the use of different 
outcome measures and statistical methods within the studies.  
Primary outcome: being employed  
24 to 18 months before start of ART  
Neither Bor et al. 2012 or Larson et al. 2013 found a statistically significant difference between 
HIV+ persons and healthy participants in employment status. Bor et al. 2012 found no difference 
in being employed or not, OR 0.79 (95% CI 0.61 to 1.02), whereas Larson et al. 2013 found no 
difference in number of days worked per month, MD -0.05 days (95% CI -0.50 to 0.40).  
6 to 0 months before start of ART  
Bor et al. 2012 and Larson et al. 2013 both found a significant decrease in employment 6 months 
prior to the start of ART for HIV+ persons in comparison to healthy participants in the work 
force. Bor et al. 2012 reported the HIV+ person more likely to be unemployed, with an OR of 
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0.50 (95% CI 0.26 to 0.47). Similarly, Larson et al. 2013 found HIV+ persons to have worked 
significantly less, with a MD of -1.28 days (95% CI -1.65 to -0.91).  
At ART initiation 
At the time of ART initiation, both studies observed a continual downward trend, with the lowest 
levels of employment for HIV+ participants. Bor et al. 2012 found an OR 0.35 (95% CI 0.26 to 
0.47), meaning a three-fold lower rate of employment in the HIV+ participants when compared 
to the healthy persons. The findings of Larson et al. 2013 were similar, with a MD of -8.49 (95% 
CI -9.57 to -7.41), translating to an 8 to 9 days’ difference in days worked per month between 
the index and reference groups.  
6 months after ART initiation  
Bor et al. 2012 reported an OR of 0.38 (95% CI 0.28 to 0.52), indicating that HIV+ persons 
were still less likely to be employed after 6 months on ART than the reference group. However, 
in Larson et al. 2013, the difference in employment between healthy participants and HIV+ 
persons decreased immediately after the start of ART. Larson et al. 2013 reported a MD of 0.08 
days (95% CI 0.05 to 0.11), meaning that HIV+ persons on ART had worked only slightly less 
than participants of the healthy reference group.  
18 to 24 months after ART initiation  
Bor et al. 2012 reported an OR of 0.44 (95% CI 0.31 to 0.62), representing a significantly lower 
likelihood of being employed for HIV+ participants on ART when compared to the healthy 
work force.  
Larson et al. 2013 reported a MD of -1.22 days (95% CI -1.74 to - 1.07), meaning that the HIV+ 
persons had worked a little less per month than the healthy workers in the reference group.  
36 to 60 months after ART initiation  
Bor et al. 2012 found similar employment rates in both groups, with an OR of 0.73 (95% CI 
0.42 to 1.28) at 36 to 60 months post-ART initiation. Additionally, Bor et al. 2012 measured 
“unemployment due to illness”, “job loss spells”, and “resides in surveillance area”; we did not 
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include these figures in our review due to their reciprocal nature to the employment outcomes 
measured above. We made this decision to prevent double counting of outcomes. The OR of 
2.17 (95% CI 1.31 to 3.58) for unemployment due to illness at ART initiation declines to 0.70 
(95% CI 0.32 to 1.55) by 18 to 24 months post-ART.  
5.3.1.2 HIV+ persons utilizing ART versus HIV+ persons pre-ART  
We found three CBA studies (2748 participants) comparing HIV+ persons on ART with HIV+ 
persons pre-ART. Thirumurthy et al. 2011 measured RTW by the number of hours worked in 
the past week. The study obtained follow-up data every 6 months, culminating at 24 months 
post-ART initiation. The authors used linear regression analysis and a dummy coding system 
that coded for either all workers at different follow-up or for those on ART only at follow-up. 
Thus the results are expressed as the number of hours that the group on ART worked more than 
the average cohort. Some of the participants got ART in between follow-up. The authors 
excluded these participants from the analysis.  
Nannungi et al. 2013 and Linnemayr et al. 2013 measured RTW as a binary ’yes’ or ’no’ 
outcome, by whether or not the participant engaged in work activities in the last seven days prior 
to the interview. Nannungi et al. 2013 reported percentages of participants who had RTW who 
were not employed at baseline as a change in work status at 6 and 12 months. Linnemayr et al. 
2013 reported the data graphically; we could not obtain raw data for this review. In future 
updates of this review, we will present the outcomes for participants currently working at 
baseline (0 months), 6 months, and 12 months, if we are able to obtain the raw data at that time. 
Additionally, Nannungi et al 2013 and Linnemayr et al 2013 also document the impact of ART 
over time.  
Primary outcome: RTW  
6 months after ART initiation  
Participants who initiated ART worked 11.95 hours (95% CI 6.75 to 17.15) more per week than 
the average of the HIV+ cohort of ART and pre-ART persons, which was 3.7 hours 
(Thirumurthy et al. 2011).  
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Nannungi et al. 2013 reported that of those on ART not working at baseline (n = 88), 50.9% 
returned to work (n = 45). Of the pre-ART group unemployed at baseline (n = 57), 48.8% were 
at work at 6 months (n = 28).  
Of those on ART working at baseline (n = 169), 81.4% were still working at 6 months (n = 138). 
In the pre-ART group, of those working at baseline (n = 168), 84.5% were still employed at 6 
months (n = 142) (P value = 0.000). Overall, 53% of those on ART (n = 136) were working 
compared to 47% of those in the pre-ART group (n = 106) at 6 months. However, the pre-ART 
group had more favorable predictive factors.  
12 to 24 months after ART initiation  
Long-term follow-up indicated a 12.1 hour (95% CI 6.99 to 17.21) increase in hours worked per 
week at the end of 24 months for the baseline ART group compared to the average of the cohort, 
which was 21 hours (Thirumurthy et al. 2011). Nannungi et al. 2013 reported continued 
improvement in employment status at 12 months after ART initiation; of those on ART and not 
working at baseline (n = 88), 55.6% had returned to work (n = 49). Of those in the pre-ART 
group unemployed at baseline (n = 57), 50.0% had RTW at 12 months (n = 29). However, the 
pre-ART group had strong predictive characteristics for regaining employment compared to 
ART group.  Of those on ART working at baseline (n = 169), 87.7% were still working at 12 
months (n = 148). In the pre-ART group, of the 74.5% working at baseline (n = 168), 75% were 
still employed at 12 months (n = 126).  
Overall, 46% of those on ART (n = 118) were working compared to 54% of those in the pre-
ART group (n = 121) at 12 months. However, the pre-ART group had more males, better 
physical health functioning and higher CD4 count, which are the strongest predictors of 
employment. After adjusting for gender, age, physical health functioning, education, 
relationship status and CD4 count, the ART group was more likely to be employed than the pre-
ART group (OR 1.56, 95% CI 1.15 to 2.12) at 12 months follow up. Linnemayr et al. 2013 
found a greater likelihood of employment for the ART group compared to the pre-ART group 
(OR 1.88, 95% CI 1.47 to 2.41) at 12 months follow-up.  
The meta-analysis for Linnemayr et al. 2013 and Nannungi et al. 2013 found an increased 
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likelihood of employment for those on ART (OR 1.75, 95% CI 1.44 to 2.12) (Analysis 1 and 
Table 1). 
 
Heterogeneity: Chi2 = 0.87, df = 1 (P = 0.35); I2 =0.0% Test for overall effect: Z = 5.70 (P < 
0.00001)  Test for subgroup differences: Not applicable.  
Table 1: Summary of Findings 
Anti-retroviral therapy compared with no ART for HIV 
 
Patient or Population: Working age adults with HIV 
Settings: Uganda 
Intervention: ART 
Comparison: Not on ART 
Outcomes Assumed 
Likelihood 
Corresponding 
Likelihood 
Relative 
Effect  
(95 % 
CI) 
No. of 
Participants 
(studies) 
Quality of 
evidence 
(GRADE) 
 Not on ART ART OR   
 
 
Employed at 12 months  
follow-up 
 
710 per 1000 
 
811 per 1000 
 
1.75 
(1.44 to 
2.12) 
 
1084 
(2) 
 
 
Very low¹ 
 
*The basis for the assumed likelihood (e.g. the median control group risk across studies) is provided in footnotes. The 
corresponding likelihood (and its 95% confidence interval) is based on the assumed risk in the comparison group and the 
relative effect of the intervention (and its 95% CI). 
CI: Confidence interval; RR: Risk Ratio; ART: Anti-retroviral therapy 
 
 
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect. 
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may 
change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is 
likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
 
1 Downgraded the quality of evidence because of limitations in study design as a non-randomized studies, as well as a HIGH 
of bias for baseline comparability, UNCLEAR for incomplete outcome data due to a lack of reporting of attrition for controls, 
and HIGH for adjustment for confounding . 
 
5.3.2 Vocational interventions 
5.3.2.1 Vocational therapy versus no vocational therapy  
Primary outcome: RTW  
Martin et al. 2012 measured outcomes at 6 month intervals beginning at baseline and continuing 
at 6, 12, 18, and 24 months, however the authors did not report these follow-up results, only 
providing a table of “estimated transition rates” in and out of employment based on a Markov 
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model for the outcomes. We requested further information, but the authors did not provide it.  
5.3.3 Grading of the evidence 
We used the GRADE approach to assess the quality of the evidence. All three observational 
studies, that is Bor et al. 2012, Larson et al. 2013, and Thirumurthy et al. 2011, started with a 
low-quality evidence rating, and the RCT, that is Martin et al. 2012, began at high rating as 
prescribed by the GRADE approach protocol (Appendix 2).  
5.3.3.1 HIV+ persons utilizing ART versus healthy participants  
We rated the evidence in this comparison to be very low quality. We downgraded the quality of 
evidence based on a high risk of bias due to limitations in study design and implementation. We 
did not downgrade the quality of the evidence due to indirectness because we judged there to be 
no limitations due to the use of direct populations, comparable interventions with similar control 
groups, and no use of surrogate data. Unexplained heterogeneity or inconsistency in the results 
showed no limitations for further downgrading of the evidence. We downgraded the quality of 
the evidence further based on imprecision, which was due to wide confidence intervals in both 
studies. We did not find evidence to downgrade for publication bias.  
We found no justification for upgrading the quality of evidence. The magnitude of effect was 
not large, there was no dose-effect relation, and the studies did not exclude all confounding.  
5.3.3.2 HIV+ persons utilizing ART versus HIV+ persons pre-ART  
We graded the quality of evidence for this comparison as very low. We found no reason to 
downgrade the quality of evidence because of problems in allocation concealment and blinding. 
We downgraded the quality of evidence for limitations in study design implementation due risk 
of bias for baseline comparability, lack of adjustment for confounding and incomplete attrition 
data. We did not find any reason to downgrade for the indirectness of the evidence in this 
comparison. We found no sign of indirect evidence or use of surrogate data in any study. There 
was no reason to downgrade the quality of the evidence based on unexplained heterogeneity or 
inconsistency in the results or for publication bias. We found no justification for upgrading the 
quality of evidence. The magnitude of effect was not large, there was no dose-effect relation, 
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and the studies did not exclude all confounding.  
5.3.3.3 HIV+ utilizing vocational therapy versus HIV+ not utilizing vocational therapy 
We graded the quality of evidence for this comparison as very low. We downgraded the quality 
of evidence based on limitations in study design and implementation, as the study had a high 
risk of bias due to a lack of reporting of allocation concealment and loss to follow-up. 
Furthermore, the study was unblinded and the use of selective reporting necessitated another 
downgrade of the quality of evidence. We also downgraded the quality of the evidence for 
indirectness of the evidence. The authors did not report any follow-up data. As only a single 
study provided evidence for this comparison, there was no need to downgrade the quality of the 
evidence because of unexplained heterogeneity or inconsistency in the results or because of 
publication bias. Imprecision of the results in the form of complicated, unjustified statistical 
analysis of unclear outcomes necessitated downgrading the quality of the evidence further.
6 DISCUSSION    
6.1 Summary of main results   
We found very low-quality evidence in five studies that ART for HIV+ persons improves ability 
to work and maintain employment. The magnitude of the intervention effect is unclear due to 
differing results between comparisons (HIV+ vs. Healthy; HIV+ on ART vs. HIV+ pre-ART). 
The studies indicated that ART does not fully restore work capacity in HIV+ persons compared 
to healthy individuals. Two years after the start of ART, HIV+ persons still worked fewer days 
than healthy people. Five years after the start of ART there was a 27% greater unemployment 
rate among HIV+ people. However, the studies comparing HIV+ persons on ART with HIV+ 
person not yet on ART, indicate that ART recipients are almost twice as likely to be employed 
than HIV+ person pre-ART. Based on two studies of 33,379 participants (Bor et al. 2012, Larson 
et al. 2013), very low-quality evidence showed that HIV+ people utilizing ART worked less 
prior to ART initiation and got increasingly employed after ART initiation. Although 
employment increased after ART initiation, neither study showed full recovery of employment 
for the HIV+ index group in comparison to the healthy reference group during the follow-up 
period.  
Two studies showed a similar trend in outcomes over a four-year period (Bor et al. 2012, Larson 
et al. 2013). The HIV+ persons index and healthy control group showed no statistical difference 
at 24 months pre-ART initiation. However, for the HIV+ persons, likelihood of employment 
and number of days worked per month declined significantly by six months prior to the start of 
ART. At the start of ART, unemployment in HIV+ persons was high in comparison to the 
healthy reference group. Larson et al. 2013 reported that employment outcomes improved six 
months after ART initiation and continued to increase at 18 to 24 months after the start of ART. 
Although there was improvement, neither Bor et al. 2012 nor Larson et al. 2013 indicated a full 
recovery of employment outcomes by the HIV+ persons on ART. The rate of improvement 
varied between the two studies. At 18 to 24 months post-ART initiation, Larson et al. 2013 
reported that HIV+ persons worked approximately one day less than healthy participants. 
However, at 18 to 24 months post- ART initiation, Bor et al. 2012 reported a likelihood of 
employment for HIV+ persons on ART as less than half that of the healthy reference group. Bor 
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et al. 2012 reported statistically significant differences between the employment outcomes of 
the index group and those of the reference group until 36 to 60 months post-ART initiation. The 
differences between the results of the two studies can be partially accounted for by their use of 
different outcome measures. Larson et al. 2013’s measure of number of days worked notes 
smaller improvements in labor outcomes, whereas Bor et al. 2012’s absolute outcomes of 
employed/unemployed restricted the intervention from showing smaller increases in labor 
productivity. Linnemayr et al. 2013 and Nannungi et al. 2013 both reported improved RTW 
outcomes in HIV+ persons on ART in Uganda over a 12 month period. At baseline, the ART 
group had higher unemployment than the pre-ART group. Both studies indicated the most 
significant improvement in employment outcomes in the first 6 months for HIV+ persons on 
ART. Similar to the findings of Bor et al. 2012 and Larson et al. 2013,the number of those 
employed continued to rise after 12 months on ART, although not as dramatically as in the first 
6 months. Half of those who were unemployed at baseline returned to work at six months in 
both the ART and pre-ART groups in one study (Nannungi et al. 2013). Although, it is important 
to note that the characteristics of the pre-ART group were more favorable to employment, due 
to a higher number of males and better overall health. Thereby, underestimating the overall 
effect of the intervention. When the analysis was adjusted for gender and health status, the 
likelihood of being employed favored the ART group. Of those who were employed at baseline, 
a larger percentage of the ART group remained employed at 12 months follow up than in the 
pre-ART group. The meta-analysis indicated a higher likelihood of employment in the ART 
group when considering the impact of ART over time (Linnemayr et al. 2013, Nannungi et al. 
2013). Thirumurthy et al. 2011 measured employment outcomes in hours worked per week, 
indicating improvement in employment outcomes after ART initiation over HIV+ people who 
were pre-ART. The results indicate an intervention effect for ART improving the number of 
hours worked per week. In the analysis, the combined group of those on ART and those pre-
ART worked an average of 21 hours per week, where the ART group alone worked 
approximately 32 hours per week to 24 months follow up.  
From the Bor et al. 2012 and Larson et al. 2013 studies, we know that without ART, 
unemployment rises considerably. Apart from ART, no other factors have been identified by the 
literature to support the increased labor productivity findings and employment outcomes of 
Linnemayr et al. 2013, Nannungi et al. 2013, and Thirumurthy et al. 2011. Martin et al. 2012 
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found no evidence of the effectiveness of vocational rehabilitation interventions. As our 
systematic search yielded no studies on psychological interventions, we cannot say if they help 
or not.  
6.2 Overall completeness and applicability of the evidence   
The importance of interventions to help HIV+ persons to RTW has been highly stressed. 
However, surprisingly few intervention studies have been conducted in this area.  The studies 
we found had been conducted in countries with a high prevalence of HIV, that is South Africa, 
Kenya, and Uganda, as well as in countries with a lower prevalence of HIV that is India and the 
United States. There were no studies from Europe, Latin America, or Australia. Given the 
differences in social security legislation, it is unclear if the evidence applies to European 
countries. Furthermore, evidence from one study suggested that ART interventions conducted 
in rural settings show a stronger effect. This might be due to accessibility of employment for 
farmers who are self-employed or working in the informal sector, whereas urban participants 
may have greater difficulty reassessing previous employment, particularly in areas with higher 
formal-sector development (Linnemayr et al. 2013). Of the five included pharmacological 
studies, only one study, Linnemayr et al. 2013, identified rural participants (OR 2.91, P value 
less than 0.01, t-statistic 4.77) from urban participants (OR 1.40, P value less than 0.05, t-statistic 
2.57) and analyzed the data separately. Two other studies identified mixed urban and rural 
residency among participant demographics, but did not perform subgroup analysis of the data 
(Bor et al. 2012; Rosen et al. 2010). Nannungi et al. 2013 used data from urban clinics. Larson 
et al. 2013 focused exclusively on tea plantation workers and therefore must be considered 
separately, as all the participants worked for the same employer. The lack of subgroup analysis 
between rural and urban groups hindered applicability of the evidence across different 
socioeconomic and geographical locations. Part and parcel of the rural/urban issue, the nature 
of employment, whether formal or informal, is not consistently distinguished throughout the 
studies, which may also contribute to a lack of applicability of the evidence by not providing a 
full picture of the effect of ART on different careers and their RTW outcomes.  
Research suggests that women are at higher risk of unemployment overall than men. Dray-Spira 
(2006) highlighted the disproportionate loss of employment for women. In this review, only by 
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the study by Thirumurthy et al. 2011 supports this finding. Three studies stratified outcome data 
by gender (Thirumurthy et al. 2011, Larson et al. 2013, Linnemayr et al. 2013); however, the 
studies yielded conflicting results and were unable to fully account for the differences between 
sexes. Larson et al. 2013 and Linnemayr et al. 2013 reported potentially better employment 
outcomes for women. Larson et al suggested that women’s improved employment outcomes 
could be due to the increased likelihood of transfer to less physically demanding work. However, 
Linnemayr et al. 2013’s statistically insignificant findings for males could be due to the small 
male sample size and therefore insufficient power to detect the actual effect. In contrast, 
Thirumurthy et al. 2011 reported better employment outcomes for males. Thirumurthy et al. 
2011 hypothesized that discrimination among the sexes segregates employment opportunities 
in the KwaZulu-Natal Umkhanyakude District, and these differences could play a role in HIV+ 
peoples’ ability to maintain or return to employment. Therefore, the gender component of RTW 
outcomes needs further exploration. Interventions need to be tailored to suit the needs of each 
sex, confounding for different societal, cultural, economic, and physical factors specific to each 
gender within a specified population. The lack of these adjustments may diminish the 
confidence of the intervention effect.  
Unfortunately, we could not include all potentially relevant studies in this review. Baran 2012 
examined multiple ART therapies in relation to healthcare costs and economic productivity for 
employers. This data could contribute to understanding the cost-effectiveness of ART programs 
as a secondary outcome. However, AbbVie Pharmaceutical Group funded the study and would 
not approve the release of necessary unpublished data for our use. The study examined three 
different types of ART medications, highlighting the differences in outcomes for participants 
based on the specific ART medication combination they received (Baran et al 2012). None of 
the pharmacological interventions in this review accounted for differences in medication 
combinations. Had researchers of the ART studies conducted subgroup analysis, intervention 
effects could have been associated with specific treatment regimens. Although the HIV+ 
participants were drawn from a single geographic area or treatment center where a specific ART 
medication combination may be most common, there is no evidence to indicate that participants 
received the same ART medication combinations or regimens. Therefore, research in regards to 
specific ART medication combinations, such as in the Baran et al. 2012 study, could have shown 
differences in employment outcomes based on different ART medication combinations. In 
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addition, we excluded a non-intervention, modeling study that examined the secondary outcome 
of cost-effectiveness of ART programs by comparing estimated total program costs with select 
economic benefits of ART (1. restored labor productivity among workers with AIDS, 2. orphan 
care expenditures avoided because of parent survival due to ART, 3. delayed end-of-life care 
costs associated with AIDS-related death). Resch et al. 2011 reported an estimated expenditure 
of USD 14.2 billion for ART from 2011 to 2020 for the South African cohort of 3.5 million 
people. The study estimated a return on investment of USD 12 billion to USD 34 billion through 
improved labor productivity, averted orphan care expenses, and deferred medical treatment for 
end-of-life care and opportunistic infections. (Resch et al. 2011) 
One other prospective cohort study, which produced three-year and five-year follow-up 
publications, Rosen et al. 2010 and Rosen et al. 2014, examined the economic well-being of 
ART patients in South Africa. We excluded the study, as it did not meet our inclusion criteria 
due to a lack of a control group. However, the findings showed a continued increase in 
employment from 32% to 44% between the start of ART and the five-year follow-up. These 
findings support the findings in all five included CBA ART studies (Thirumurthy et al. 2011, 
Bor et al. 2012, Larson et al. 2013, Linnemayr et al. 2013, Nannungi et al. 2013). Of the 248 
participants who were unemployed but looking for work at baseline, 39% (n = 96) RTW, and 
of the 96 participants who were unemployed at baseline and not seeking work, 30% (n = 29) 
RTW and 53% (n = 51) were now actively seeking employment. Furthermore, the study 
examined outcomes outside of our predetermined outcomes, including the probability of 
experiencing pain or fatigue in the last week, the probability of being able to perform normal 
activities over the previous five-day work week, and reliance on external support in the form of 
a caretaker. The data collected demonstrated a decrease in reporting pain in the previous week 
from 69% at baseline to 17% (P value less than 0.001) and a decrease in reporting fatigue in the 
previous week from 62% at baseline to 7% (P value less than 0.001) after five years. These 
health improvements coincide with findings by Larson et al. 2013, where the measure of number 
of days worked allowed for smaller improvements in labor outcomes to be noted. Therefore, 
reductions in pain and fatigue due to ART may incrementally improve a person’s capacity to 
work.  
Three included ART studies examined strict dichotomous outcomes of employment or 
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unemployment (Bor 201, Linnemayr et al. 2013, Nannungi et al. 2013), whereas the other two 
ART studies examined reduction in the labor productivity of HIV+ persons without a definitive 
loss of employment or reemployment (Thirumurthy et al. 2011, Larson et al. 2013). The overall 
evidence did not account for specific reasons of unemployment but assumes loss of employment 
is solely attributable to HIV status. Therefore, a pharmacological intervention targeting loss of 
employment due to HIV would not produce the same effect on RTW outcomes for a HIV+ 
person whom lost their job for other reasons.  
Two included studies evaluated the effects of CD4 counts or progression of the disease at 
initiation of the intervention (Linnemayr et al. 2013, Nannungi et al. 2013). Although the index 
group criteria in the Thirumurthy et al. 2011 study required participants to a have a CD4 count 
less than 200, the analysis did not take into account varying levels of health status. Along the 
same vein, not all of the studies clearly distinguished HIV+ participants from participants with 
fully developed AIDS. Only two studies clearly indicated the use of World Health Organization 
(WHO) guidelines for diagnosis of HIV/AIDS and ART eligibility (Linnemayr et al. 2013, 
Nannungi et al. 2013). The differing levels of health status, by either CD4 counts or HIV versus 
AIDS, at initiation of the intervention could impact the outcomes.  
In 2012, the WHO reported varying levels of HIV prevalence in working-age populations (15 
to 49 years) among the countries examined in the pharmacological ART intervention studies: 
South Africa (17.9%), Kenya (6.1%), Uganda (7.4%), and India (0.3%) (WHO 2013a, WHO 
2013b, WHO 2013c, WHO 2013d). Within these countries, the overall makeup of the HIV+ 
population varies. These statistics indicate diverse social and political environments for HIV 
within each population. ART coverage among HIV+ persons also varies between countries: 
South Africa (80%), Kenya (73%), Uganda (64%), and India (50%). Therefore, the ART 
environment, available knowledge, access to other HIV services, and individual perceptions 
may also influence employment outcomes within a specific population. The cultural, social, 
educational, political, and economic diversity of each of the countries included in this review 
should be considered when examining the effectiveness of the interventions by their location. 
Furthermore, none of the studies controlled for possible co-occurring interventions, which may 
have positively altered the intervention effect.  
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6.3 Quality of the evidence   
See Appendix 2 for GRADE ratings of the quality of the evidence. 
6.3.1 Pharmacological interventions 
6.3.1.1 HIV+ persons utilizing ART versus healthy (non-HIV+) individuals  
The very low-quality evidence GRADE rating for the two-study comparison did not encourage 
the acceptability of the results of a positive intervention effect (Bor et al. 2012, Larson et al. 
2013).  
6.3.1.2 HIV+ persons utilizing ART versus HIV+ persons pre-ART  
The very low-quality evidence GRADE rating for the three-study comparison degraded the 
reliability of the positive intervention effect of ART (Thirumurthy et al. 2011, Linnemayr et al. 
2013, Nannungi et al. 2013).  
In both comparisons, a more definitive answer to the effectiveness of ART requires an 
improvement in the quality of the body of evidence.  
In both comparisons, a more definitive answer to the effectiveness of ART requires an 
improvement in the quality of the body of evidence. 
6.3.2 Vocational interventions 
6.3.2.1 HIV+ persons utilizing vocational therapy versus HIV+ persons not utilizing 
vocational therapy  
The very low-quality evidence GRADE rating for the single-study comparison devalues the 
authenticity of the suggested positive intervention effect of mixed vocational and psychological 
rehabilitation (Martin et al. 2012).  
To the best of our knowledge, no studies have produced evidence of a positive intervention 
effect that merits the use of mixed vocational and psychological interventions to improve 
employment outcomes. Therefore, justification for mixed vocational and psychological 
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interventions requires more, higher-quality studies.  
6.4 Potential biases in the review process   
We allowed the inclusion of studies with unemployed participants at time of intervention 
initiation, which required a relaxation of our predetermined inclusion criteria (Thirumurthy et 
al. 2011, Bor et al. 2012 Linnemayr et al. 2013, Nannungi et al. 2013). This decision may have 
potentially influenced the result.  
Language bias is irrelevant in this review, as we excluded no studies on the basis of publication 
language.  
6.5 Agreements and disagreements with other studies or reviews   
To our knowledge, this is the first systematic review to analyze the effects of interventions 
designed to improve employment out- comes for HIV+ persons.   
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7 CONCLUSIONS  
7.1 Implications for practice   
We found very low-quality evidence for an increase in days worked and employment rates 
among HIV+ persons who were started on ART compared to healthy people to a level only a 
little under that of healthy workers. Additionally, we found very low-quality evidence for 
improvement in RTW outcomes for HIV+ persons on ART compared to HIV+ persons who are 
pre-ART. There was no evidence of the effectiveness of vocational rehabilitation. No studies 
supported psychological or other interventions.  
7.2 Implications for research   
Further research is required and should include more RCTs of vocational, psychological, 
educational, and support interventions. Researchers should account for all possible influences 
on employment outcomes, such as co-occurring interventions available within a treatment 
population. To improve the quality of the evidence, studies should fully report predetermined 
outcomes as well as account and compensate for attrition. All possible confounders (gender, 
age, socioeconomic status, migration, and disease severity) should be analyzed. Researchers 
should focus specifically on differences in employment outcomes by gender to help fine-tune 
the potency of interventions. Future pharmacological studies should clarify ART therapy 
regimens and differentiate between cART (combination antiretroviral therapy) prescriptions.  
7.2.1 RCTs 
More RCTs would improve the quality of evidence. Although the RCT study design is ideal for 
showing effectiveness, it is an unethical approach to conduct pharmacological ART 
interventions. However, RCTs can be effectively utilized for vocational and psychological 
interventions. Given the probably modest effect sizes and a large risk of confounding, RCTs 
with a follow-up of at least one year would be ideal.  
7.2.2 CBA studies 
CBA studies present a solution to the problem of studying ART interventions. However, 
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additional studies with higher-quality evidence are needed.  
7.2.3 Blinding 
All future studies should ensure blinding of outcome assessors, even if blinding of participants 
and personnel is not possible.  
7.2.4 Other interventions 
Although our comprehensive search criteria yielded only five pharmacological ART 
interventions and one mixed vocational and psychological counseling intervention, many other 
intervention possibilities exist. For example, income support interventions could possibly 
reduce the stress related to financial burden. Financial security may improve well-being and 
quality of life, whereas stress may potentially lead to expedited disease progression followed by 
job loss. Researchers could explore job or career field-specific intervention programs that focus 
on meeting the specific needs of the employee within the given profession. It is theorized that 
involvement in meaningful work improves one’s sense of self-worth in addition to providing 
many other benefits. Caretaker or family educational interventions might encourage RTW by 
dispelling the myth that HIV+ people should not work and must play the ’sick role’. Educational 
interventions for caretakers or family could furthermore enhance the support system of the HIV+ 
individual, thereby boosting RTW outcomes. Educational interventions for employers could 
assist companies in mindfully accommodating HIV+ employees, retaining HIV+ employees, 
and decreasing absenteeism. The aforementioned list is not exhaustive of potential interventions, 
but merely suggests the current knowledge gap.  
7.2.5 Reporting 
All of the studies in our review indicated a high risk of bias due to incomplete outcome data and 
selective reporting. Future studies should employ all appropriate methods to reduce risk of bias, 
thereby improving the quality of evidence.
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9 DIFFERENCES BETWEEN PROTOCOL AND REVIEW  
The protocol for this review was published under the title, “Work arrangements for sustaining 
employment in workers with HIV”, however, we changed the title to “Interventions for 
improving employment outcomes for workers with HIV” as we considered this title to be more 
accurately describe the review.  
We also included studies that allowed for participants to be unemployed at the time of diagnosis, 
in order to provide the most comprehensive picture of employment outcomes by accounting for 
job loss trends prior to diagnosis. This alteration accounts for the effects of HIV on employment 
being prior to diagnosis. 
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APPENDICES 
Appendix 1: CHARACTERISTICS OF STUDIES TABLES 
A. Characteristics of included studies   
Bor et al. 2012 
Study Component Description 
  
Methods CBA study (retrospective) 
Participants 32,321 population cohort of all working-age (18-59) people who were members of a 
household in Africa Centre for Health and Population Studies’ population surveillance 
area during the 10-year follow-up period, excluding HIV+ persons not accessing ART. 
(South Africa) 
Index group: 2027 HIV+ persons 
Reference group: 30,294 
Intervention Intervention: Pharmacological, ART through the Hlabisa HIV Treatment and Care 
Program 
Control: Drawn from the same population, but non-HIV, untreated, apparently healthy 
Outcomes Employment: Employment status measured as ’yes’ or ’no’ 
Authors also assessed: 
1) Unemployment due to illness, 
2)  Residence in surveillance area (migration indicator) 
3) Physical function: Walk 5 km without stopping, carry heavy objects for 20 
meters without stopping, participate in vigorous activities 
4) Immunological status: CD4+lymphocyte count 
 
Notes ART  
Risk of Bias 
Bias Authors’ 
judgement 
Low, High, 
Unclear 
Support for judgement 
14. Blinding (subjects) LOW Retrospective data collected and cross-referenced from a cohort’s 
surveys of socio-demographics and health data. Participants were 
unaware they were under investigation for the specific intervention 
at the time of the cohort surveys 
 
15. Blinding (outcome 
assessors) 
LOW  Not blinded. Retrospective data collected and cross-referenced 
from a cohort’s surveys of socio-demographics and health data. 
Objective outcomes that should have been unaffected by blinding 
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16. Retrospective 
unplanned sub-group 
analysis  
UNCLEAR Retrospective study, data dredging not clear. 
17. Follow-up LOW Follow-ups conducted for both index and reference at 8-5 
years, 5-3 years, 3-2.5 years, 2.5-2 years, 2-1.5 years, 1.5-1 years, 
1-0.5 year both pre- and post-ART initiation 
18. Statistical tests LOW Odds ratio, t-statistics, and hazards ratio 
19. Compliance UNCLEAR Compliance to ART was not monitored or insured. ART 
adherence is required for survival, therefore compliance is highly 
likely 
20. Outcome measures LOW All predetermined outcome measures were analyzed and 
reported 
21. Selection Bias 
(population) 
LOW All participants were collected from South Africa’s Africa 
Centre population surveillance area in the Hlabisa subdistrict.The 
study used all HIV+ persons who were utilizing ART during the 10-
year follow-up period of the Africa Centre’s population 
surveillance study 
22. Selection Bias (time) LOW All individuals residing in the surveillance area were monitored 
between 2001-2010 and for inclusion in the study were required to 
have lived in the surveillance area 6months prior to the 
establishment of the Hlabisa HIV Treatment and Care Program 
23. Randomization HIGH  No randomization. Retrospective cohort study. 
24. Allocation Concealment  UNCLEAR Retrospective study of a cohort. Participants were not assigned by 
the research team, but were predetermined by health status. Did not 
report the use of adequate sequence generation or allocation 
concealment techniques 
25. Adjustment for 
confounding 
HIGH  Migration confounder addressed. Gender differences not addressed. 
Age differences not addressed. SES differences not addressed. 
Disease severity not addressed. 
26. Incomplete outcome 
data 
HIGH  20.4%attrition in index group addressed. No data reported 
for control group 
Baseline Comparability HIGH  Differences in gender proportions: Index group 80.1% female and 
reference group 59.9% female. 
Age groups were disproportionate: (18-25 years) index 17.5%, 
reference 49.4%; (25-34 years) index 38.7%, reference 21%; (35-
44 years) index 31%, reference 18.2% 
SES not specifically reported, but > 12 years of school was also 
disproportionate between groups: index 33.9%, reference45.1% 
Disease severity was incomparable in the index group 
(HIV+ persons) and reference group (healthy and 
undiagnosed,asymptomatic HIV+ people) 
ART: antiretroviral therapy 
CBA: controlled before-after study 
 
  
Larson et al. 2013 
Study Component Description 
  
Methods CBA study (retrospective) 
Participants Index: 237 HIV+ tea pluckers with a CD4 count < 350 who began ART between 
2004 
and 2007 
Control: Pool of workers from the 13,178 general work force population 
(Kenya) 
Intervention Intervention: Pharmacological, ART 
Control: Healthy, untreated general work force 
Outcomes Employment: 
1. Total days working per month 
2. Days spent plucking tea per month 
3. Total kg of tea harvested per month 
4. Total income per month 
Notes HIV 
Risk of Bias 
Bias Authors’ judgement 
Low, High, Unclear  
Support for judgement 
   
14. Blinding (subjects) LOW Participants were unaware of intervention. 
15. Blinding (outcome 
assessors) 
LOW Not reported. Objective outcomes that should have 
been unaffected by blinding. 
16. Retrospective unplanned 
sub-group analysis 
  
UNCLEAR Retrospective study, data dredging not clear. 
17. Follow-up LOW Follow-ups conducted for both index and reference 
at 6-month intervals beginning 24 months pre-ART 
until 24 months post-ART 
18. Statistical tests LOW Mean difference (95% confidence interval) 
19. Compliance UNCLEAR Compliance to ART was not monitored or insured. 
ART adherence is required for survival, therefore 
compliance is highly likely 
20. Outcome measures LOW All predetermined outcome measures were 
analyzed and reported 
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21. Selection Bias 
(population) 
LOW Study used all HIV+ persons who visited the tea 
plantation hospitals and healthcare clinics. All 
participants were employees of two tea 
plantations in the Kericho District of Kenya. 
However, it is important to note that some 
participants in the reference group were likely 
HIV+ but were undiagnosed or had not declared 
their HIV status as positive. This could have 
impacted the results 
22. Selection Bias (time) LOW All participants were monitored between 2006-
2009. 
23. Randomization HIGH No randomization for index group. Index group 
was matched with four references who were 
randomized into sub-estate groups 
24. Allocation Concealment  UNCLEAR Retrospective, non-randomized study. Did not 
report the use of adequate sequence generation or 
allocation concealment techniques 
25. Adjustment for 
confounding 
HIGH Adjustment for gender outcome differences. Age 
differences not addressed. SES differences not 
addressed. Disease severity not addressed. 
Migration differences not addressed 
26. Incomplete outcome data HIGH 6%attrition in index group addressed. No attrition 
data reported for controls. Data for workers in the 
general work force was incomplete due to a 
change in the management system resulting in the 
reassigning of employment identification numbers 
Baseline Comparability HIGH No baseline demographics were reported for the 
reference group. 
The index group mean age for women was 39.4 
(27.4-53) and for men was 39.5 (24.9-54.4). The 
average years of experience for women was 8.2 
(1-24) years and for men was 7.7 (0.5-23) years. 
Median baseline CD4 counts for women were 178 
(91-243) and for men were 153.3 (85-215) 
ART: antiretroviral therapy 
CBA: controlled before-after study 
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Linnemayr et al. 2013 
Study Component Description 
  
Methods CBA study (Longitudinal, prospective cohort) 
Participants 602 HIV+ treatment-naive clients, 18 years of age or older, who were newly 
evaluated 
for ART from 2 Joint Clinical Research Centres in Kampala (urban) and Kakira 
(rural), Uganda. 
Index: 300 HIV+ people initiating ART with CD4 count < 250 cells/mm3 (WHO 
disease stage III or IV) and had a ’treatment supporter’ 
Control: 302 HIV+ people pre-ART with CD4 count < 400 cells/mm3 
Intervention All participants underwent structured interview concerning background 
characteristics, 
physical and mental health status, and economic outcomes. Health data abstracted 
from 
patient medical records. Assessments taken at 0 and 12 months 
Index: ART provided by Joint Clinical Research Centre HIV Clinic, plus general 
HIV treatment 
Control: General HIV treatment, no ART 
Outcomes Employment: 
1. Work status in the week preceding interview 
Other health-related economic outcomes: 
2. Health interference with work (binary indicator of perceived health effect 
on work) 
3.  Pain interference ewith work in last month (5-point scale from not at all’ to 
’extremely’) 
4. Work-related self-efficacy (single visual analogue scale 0-10) 
Notes Rand Corporation (California, USA) 
Joint Clinical Research Centre (Kampala, Uganda) 
Funding: The Rockfeller Foundation, Grant No. HE007;PIGWagner 
Participants received 5000 Uganda Shillings (~USD 2.50) for completion of each 
interview 
Risk of Bias 
Bias Authors’ judgement 
Low, High, Unclear  
Support for judgement 
   
14. Blinding (subjects) UNCLEAR No blinding, however due to a dichotomous 
outcome of employed or unemployed in past 7 days, 
this should not have affected the results. 
15. Blinding (outcome 
assessors) 
LOW No blinding, objective outcomes should have been 
unaffected by lack of outcome assessor blinding. 
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16. Retrospective 
unplanned sub-group 
analysis 
  
LOW No evidence of retrospective unplanned subgroup 
analysis. 
17. Follow-up LOW Follow-ups conducted at 6 and 12 months 
in both index and reference groups. Approximately 5% 
loss to attrition 
18. Statistical tests LOW Two-tailed t-test, Chi2 test (has statistically 
lowpowerwhen study has small sample size 
(n = 602)) Performed 2 sensitivity analyses: 
1. Excluded control-group participants who began 
ART treatment but were kept in the control 
group due to intention-to-treat study design 
analysis 
2. Restricted control group to members of a similar 
health status 
19. Compliance UNCLEAR ART adherence is required for survival, therefore 
compliance, although not monitored, is highly likely. 
Eligibility for the index group required the HIV+ 
persons have a ’treatment supporter’ for adherence 
20. Outcome measures LOW All predetermined outcome measures were analyzed 
and reported 
21. Selection Bias 
(population) 
UNCLEAR Eligible patients were approached by clinic staff when 
ART eligibility was assessed. No randomization. 
Intention-to-treat analysis was utilized to avoid control-
group members changing to the index group 
22. Selection Bias (time) UNCLEAR Recruitment timeline not specified. 2008? 
23. Randomization UNCLEAR Non-randomized. Participants were predetermined to 
index and reference groups by ART eligibility status. 
24. Allocation 
Concealment  
UNCLEAR Non-randomized. Did not report the use of adequate 
sequence generation or allocation concealment 
techniques. 
25. Adjustment for 
confounding 
UNCLEAR Stratified data by gender and included physical health 
and mental health confounders. Did not account for age, 
SES, or education 
26. Incomplete outcome 
data 
LOW < 5% attrition, and all outcome data reported. 
Baseline Comparability UNCLEAR Baseline health differences between the index and 
reference groups due to disease progression and need 
for treatment. Authors claim to have performed a 
sensitivity analysis and reported that the overall results 
did not change. However, data was not presented in the 
publication. 
ART: antiretroviral therapy 
CBA: controlled before-after study 
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Martin et al.  2012  
Study Component Description 
  
Methods RCT study 
Participants 174 HIV+ persons aged 18-65 who had stopped working due to disability, were 
receiving disability services, and who were contemplating rejoining the workforce. 
(USA) 
Index group: 83 
Control group: 91 
Intervention Intervention: 
• 1-hour individual counseling sessions conducted in the beginning, middle, 
and end of the 7-week group session period 
• 13 group sessions over a period of 7 weeks 
Control: 
• 1 group session in which participants were given community referrals to 
assist in RTW 
Outcomes Employment: 
1. Full-time, part-time, temporary, or under-the-table paid employment in the 
past 6 months and average hours per week 
2. Unpaid volunteer work in the past 6 months and average hours per week 
3. Attendance at job training classes in the past 6 months and average hours per 
week 
4. Active job search for a period of 30 days or longer in the past 6 months 
Authors also assessed: 
1. Demographics in past 6 months 
2. Current health status 
Notes Contacted authors for additional information. None provided. 
Risk of Bias 
Bias Authors’ judgement 
Low, High, Unclear  
Support for judgement 
   
14. Blinding (subjects) HIGH No blinding of participants or personnel. 
15. Blinding (outcome 
assessors) 
HIGH Not reported. 
16. Retrospective 
unplanned sub-group 
analysis 
  
UNCLEAR Only baseline data was reported. No follow-up 
outcomes provided.  
17. Follow-up LOW Follow-ups conducted for both index and reference 
groups at 6, 12, 18, and 24 months 
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18. Statistical tests UNCLEAR Unable to determine appropriateness due to unjustified, 
complex data analysis and unreported follow-up 
outcome  
 
19. Compliance HIGH Compliance not insured. Dose-response analysis 
conducted but results uninterruptible 
20. Outcome measures LOW All predetermined outcome measures were reported. 
21. Selection Bias 
(population) 
UNCLEAR Participants were recruited frommultipleAIDS service 
organizations, communitymental health centers, HIV 
medical providers, and gay and lesbian centers, and may 
be disproportionate between index and reference 
groups, although reported baseline demographic 
characteristics were uniform between groups 
22. Selection Bias (time) LOW Recruited at same time. Randomized. 
23. Randomization LOW Stratified randomization procedure on education, CD4 
count, and ethnic minority status. 
24. Allocation 
Concealment  
UNCLEAR Not reported. 
25. Adjustment for 
confounding 
HIGH Not adjusted for gender; only 9-10% female in both 
groups. 
26. Incomplete outcome 
data 
HIGH All follow-up outcome data missing. Only baseline data 
provided with generalized summaries in results section. 
ART: antiretroviral therapy 
RCT: randomized control trail  
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Nannungi et al. 2013 
Study Component Description 
  
Methods CBA study (Longitudinal, prospective cohort) 
Participants 482 participants were recruited (July 2008 to August 2009) as consecutive, new 
clinic 
patients recently evaluated for ART from2HIV clinics in Kampala, Uganda 
(ReachOut Mbuya and Mulago Immune Suppression Syndrome Clinic) 
Index: 257 HIV+ persons initiating ART with CD4 count < 250 cells/mm3(WHO 
disease stage III or IV) 
Control: 225 HIV+ persons pre-ART with CD4 count < 400 cells/mm3 
Intervention All participants received HIV primary medical care (monitoring and treatment of 
infections 
and prescription of prophylactic medications) 
Index: ART plus HIV primary medical care 
Control: HIV primary medical care 
Outcomes All participants underwent structured interview concerning background 
characteristics, physical and mental health status, and economic outcomes. Health 
data abstracted from patient medical records and Medical Outcomes Study HIV 
Health Survey. Assessments taken at 0, 6, and 12 months. 
Employment: 
1. Work status; having engaged in work activity in previous 7 days (binary yes 
or no) 
2. Weekly income; last payment and number of weeks worked for this payment 
Other health-related economic outcomes: 
3. Health interference with ability to work in last month (4-point scale from 
’never’ to ’most of the time’) 
Notes Infectious Diseases Institute Makerere University (Kampala, Uganda) 
Uganda National Council of Science and Technology (Uganda) 
Rand Corporation (CA, USA) 
Participants received 6000 Uganda Shillings (~USD2.50) for completion of each 
assessment 
Risk of Bias 
Bias Authors’ judgement 
Low, High, Unclear  
Support for judgement 
   
14. Blinding (subjects) UNCLEAR No blinding, however due to a dichotomous 
outcome of employed or unemployed in past 7 days, 
this should not have affected the results. 
15. Blinding (outcome 
assessors) 
LOW No blinding, objective outcomes should have been 
unaffected by lack of outcome assessor blinding. 
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16. Retrospective 
unplanned sub-group 
analysis 
  
LOW No evidence of retrospective unplanned subgroup 
analysis. 
17. Follow-up UNCLEAR Follow-up conducted at 0, 6, and 12 months. 36% 
attrition. 
18. Statistical tests LOW Two-tailed t-tests, Chi2 tests, paired t-test, McNemar’s 
test.  
 
19. Compliance UNCLEAR As ART adherence is required for survival, compliance, 
although not monitored, is highly likely 
20. Outcome measures LOW All predetermined outcome measures were reported. 
21. Selection Bias 
(population) 
LOW Non-randomized, non-blinded recruitment of 
consecutive new clinic clients recently evaluated for 
ART 
22. Selection Bias (time) LOW All participant recruitment July 2008 to August 2009. 
23. Randomization LOW Non-randomized, ART group and control group 
predetermined by health status and WHO stages of 
disease criteria 
24. Allocation 
Concealment  
HIGH Non-randomization. Did not report the use of adequate 
sequence generation or allocation concealment 
techniques 
25. Adjustment for 
confounding 
UNCLEAR Study adjusted for changes in physical, health status, 
age, gender, education, relationship status, and CD4 
count. However, did not account for SES or mental 
health confounders 
26. Incomplete outcome 
data 
UNCLEAR 36% attrition, analysis included attrition weights for 
dropouts derived from study completion and baseline 
measures associated with ART 
Baseline Comparability HIGH As expected, baseline health differences were present 
between the index and reference groups due to disease 
progression and need for treatment. Higher percentage 
of index group was married or in a committed 
relationship than control group. Higher percentage of 
control group working and higher weekly income at 
baseline than index group. Analysis adjusted for change 
in physical health status 
ART: antiretroviral therapy 
CBA: controlled before-after study 
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Thirumurthy et al. 2011 
Study Component Description 
  
Methods CBA study  
Participants 1543 adult HIV+ persons, plus 54 caretakers and 67 children (Tamil Nadu, India) 
Index Group: 515 
Control Group: 723 
A total of 1238 participants were included in the final analysis 
Intervention Intervention: Pharmacological, ART and home visits for ART adherence support 
• Clinical care: routine medical care, diagnosis, and treatment of opportunistic 
infections 
• Nutritional supplement: nutritional assessment, counseling, 
macronutrient/micronutrient supplements 
• Home-based care: home visits for encouraging participants to make monthly 
hospital visits, social service connection for income-generating activities, 
legal services, and housing 
Control: All of the above except for ART and home visits for ART adherence 
support 
because CD4 counts were above 200 and ART was not indicated 
Outcomes Employment: 
1. Whether participants took part in economic activities during the week prior 
to interview 
2. Number of hours they worked during the week prior to interview 
3. Individual income earned in the past 30 days 
4. Individual income earned in the past 6 months 
Health status: 
1. Body mass index 
2. CD4 cell count 
3. ART initiation date 
Notes ***Participants were not required to be employed at the time of the study, however 
the study measured economic outcomes related to ART 
Risk of Bias 
Bias Authors’ judgement 
Low, High, Unclear  
Support for judgement 
   
14. Blinding (subjects) LOW No blinding, however due to a dichotomous outcome of 
employment or non-employment, this should not have 
affected the results. 
15. Blinding (outcome 
assessors) 
LOW No blinding, objective outcomes should have been 
unaffected by lack of outcome assessor blinding. 
16. Retrospective 
unplanned sub-group 
analysis 
  
LOW No evidence of retrospective unplanned subgroup 
analysis. 
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17. Follow-up LOW Same time period. 68.66% present for interviews at 24 
months 
18. Statistical tests UNCLEAR Possibly MD and SE for ART group and entire HIV+ 
cohort 
 
19. Compliance UNCLEAR Compliance to ART was not reported. However, ART 
participants did receive home visits to encourage ART 
adherence. ART adherence is required for survival, 
therefore compliance, although not monitored, is likely 
20. Outcome measures LOW All predetermined outcome measures were reported. 
21. Selection Bias 
(population) 
LOW Selected from same population. (Tamil Nadu Family 
Continuum Care Program) 
22. Selection Bias (time) LOW Recruited at the same time. 
23. Randomization HIGH Non-randomized study. Participants were 
predetermined by health status and CD4 counts 
24. Allocation 
Concealment  
UNCLEAR Non-randomization. Did not report the use of adequate 
sequence generation or allocation concealment 
techniques 
25. Adjustment for 
confounding 
HIGH Adjusted for gender. No adjustment for differences in 
disease severity. No adjustments for differences for 
SES. No adjustments for differences in age. 
26. Incomplete outcome 
data 
UNCLEAR 34.34% attrition in index group addressed. No attrition 
data reported for controls 
Baseline Comparability UNCLEAR Female percentage was 42% in the index group and 
65% in the reference group. Percentage of those who 
completed secondary education was 28%in the index 
group and 27%in the reference group.CD4 counts at 
baseline were 128.2 for the index group and 465.6 for 
the reference group 
ART: antiretroviral therapy 
CBA: controlled before-after study 
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B. Characteristics of Excluded Studies [ordered by study ID] 
Study Reason for Exclusion 
Ajithkumar 2007 No control group 
Bernell 2005 Not a RCT or CBA study 
Escovitz 2005 Kirk Employment Empowerment Project. No control group. 
Goldman 2004 No control group 
Herdt 1999 Study about AIDS prevention, not an HIV employment intervention study 
Hergenrather 2013 No control group 
Lee 2005 We sought unpublished raw data specific to HIV from the author but received 
none. The published data on general chronic diseases was not relevant to the 
other studies in the review 
Martin 2003  Not an intervention study. 
Martin 2005 Summary of ongoing study later published as Martin et al. 2012 
Maticka-Tyndale 2002 All results were qualitative. 
Resch 2011 Modeling study; not an intervention study 
Rosen 2004 Not an intervention study 
Rosen 2010 No control group 
Rosen 2014 No control group 
Rosolen 2010 Not an intervention study 
Rueda 2012 Not an intervention study 
Thirumurthy 2013 Not an intervention study 
Van der Borght 2006 Not a RCT or CBA study 
Van der Borght 2010 Not a RCT or CBA study 
CBA: controlled before-after study 
RCT: randomized controlled trial 
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C. Characteristics of Studies Awaiting Assessment [ordered by study ID] 
Baran et al. 2012 
Study Component Description 
  
Methods CBA study 
Participants  196,350 employees >18 years of age (USA) 
Interventions Pharmacological, ART 
Outcomes Employment: 
1. Sick leave 
2. Short-term disability 
3. Long-term disability 
ART cost 
Notes Poster presentation only. Contact author for full text and further 
unpublished outcome data. However, the author responded that he was 
unable to provide any unpublished data without the specific permission of 
AbbVie Pharmaceutical Group. AbbVie was contacted for authorization. 
Richard from AbbVie group is investigating my request. AbbVie would 
not release data for external publication or use 
 
 
Borwein et al. 2010 
Study Component Description 
  
Methods Not known  
Participants  Not known 
Interventions Not known 
Outcomes Not known 
Notes Original search produced only abstract. Contacted author but received no 
response. Additionally NM sought hard copies in Canada, and only poster 
abstracts were located from the Canadian Journal of Infectious Diseases 
& Medical 
Microbiology. Study was still in progress in 2010, but no further 
publication has been made. 
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Paul-Ward 2005 
Study Component Description 
  
Methods Not known 
Participants  48 HIV+ people from supportive living facilities (USA) 
Interventions ESD program 
Outcomes Not known 
Notes Study still in progress as of 2005. No later publication found. Contacted 
author but received no response 
 
 
Popiel 2010 
Study Component Description 
  
Methods Not known 
Participants  Not known 
Interventions Not known 
Outcomes Not known 
Notes Original search produced only abstract. Contacted author but received no 
response. Additionally NM sought hard copies in Canada, and only 
abstracts were located from the Canadian Journal of Infectious Diseases 
& Medical Microbiology. 
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Appendix 2: GRADE RATINGS FOR DETERMINING THE QUALITY OF THE LEVEL OF 
EVIDENCE 
Comparison  
(No. of Studies) 
HIV+ ART vs. Healthy (2) 
 
Limitations 
(Risk of bias 
in studies) 
 
HIGH risk of bias. Non-randomized retrospective studies of cohort data. Non-
blinded but should not affect the results of the study as out outcomes are objective. 
Low risk of selection bias. Low rate of attrition for index groups. High risk of bias 
for adjustments for confounding. Lack of attrition data for the control group. High 
risk of bias for baseline comparability. DOWNGRADE 
 
Directness of 
evidence 
 
 
No limitations. Populations in comparison: Kenyan tea workers (predominate 
employer in district) & South African general population in subdistrict. 
Direct populations, direct ART interventions delivered through clinics, and healthy 
control group received no intervention. No surrogate data was used.  
NO DOWNGRADE 
Consistency 
between 
studies 
 
Results consistent in both studies. Subgroup analysis was not applicable. 
NO DOWNGRADE 
Precision of 
effect size 
 
Wide confidence intervals. 
DOWNGRADE 
Publication bias  Not applicable; only two studies. 
NO DOWNGRADE 
 
Considerations for  
upgrading observational 
studies 
 
Small intervention participant numbers potentially inflate the magnitude of the 
effect. 
Dose-effect relation was explored as no data on dosage was provided. No analysis 
for confounders. 
NO UPGRADE 
 
 
Level of Evidence  
 
VERY LOW 
 
Comparison  
(No. of Studies) 
HIV+ ART vs. HIV+ Pre-ART (3) 
 
Limitations 
(Risk of bias 
in studies) 
 
HIGH risk of bias. Nonrandomized prospective cohort studies. No blinding, 
however results should be unaffected due to objective, dichotomous outcomes. 
Low risk of selection bias. Low rate of attrition for index. Unclear risk for a lack of 
attrition data for the control groups. High risk of bias for baseline comparability. 
DOWNGRADE 
 
Directness of 
evidence 
 
 
No outlying, indirect evidence. Control groups received standard care. No surrogate 
data used in any study. NO DOWNGRADE 
Consistency 
between 
studies 
Results consistent in all 3 studies.  
NO DOWNGRADE 
 83 
 
Precision of 
effect size 
 
0% Heterogeneity.  
NO DOWNGRADE 
Publication bias  All 3 studies produced evidence of the positive effect of ART on 
employment, however we did not judge this to be biased to file drawer phenomenon. 
None of the studies had pharmaceutical funding or any known conflicts of interest 
NO DOWNGRADE 
 
Considerations for  
upgrading observational 
studies 
 
Small intervention participant numbers potentially inflate the magnitude of the 
effect. 
Dose-effect relation was not explored as no data on dosage was provided. 
Incomplete analysis for confounders. Studies individually adjusted for different and 
limited confounders 
NO UPGRADE 
 
 
Level of Evidence  
 
VERY LOW 
 
Comparison  
(No. of Studies) 
Vocational Intervention vs. None (1) 
 
Limitations 
(Risk of bias 
in studies) 
High risk of bias. Allocation concealment and loss to follow-up not reported. No 
blinding and evidence of selective reporting. 
DOWNGRADE 
Directness of 
evidence 
 
No outlying, indirect evidence due to single-study comparison. Control group 
received standard care. Outcome data limitations due to missing follow-up data and 
complex, confusing reporting. 
DOWNGRADE 
Consistency 
between 
studies 
 
Only study, complete homogeneity. 
NO DOWNGRADE 
Precision of 
effect size 
 
Poorly reported, minimal outcome data. 
DOWNGRADE 
Publication bias  No evidence of publication bias.  
NO DOWNGRADE 
 
Considerations for  
upgrading observational 
studies 
 
Randomized study. Not applicable. 
NO UPGRADE 
 
 
Level of Evidence  
 
VERY LOW 
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Appendix 3: SEARCH STRATEGIES 
A. MEDLINE (Pubmed) search strategy   
14 March 2012 (by Leena Isotalo) 
#1 HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tw] OR hiv-1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw] OR hiv infect*[tw] 
OR human immunodeficiency virus[tw] OR human immunedeficiency virus[tw] OR human immuno-deficiency virus[tw] OR human 
immune-deficiency virus[tw] OR ((human immun*[tw]) AND (deficiency virus[tw])) OR acquired immunodeficiency syndrome[tw] 
OR acquired immunedeficiency syndrome[tw] OR acquired immuno-deficiency syndrome[tw] OR acquired immune-deficiency 
syndrome[tw] OR ((acquired immun*[tw]) AND (deficiency syndrome[tw])) OR HIV/AIDS[tw] 
#2 absenteeism[tw] OR absenteeism [MeSH] OR "work disability"[tw] OR "sick leave"[tw] OR "sick leave"[MeSH] OR "sickness 
absence"[tw] OR employment [MeSH] OR employment [tw] OR "re-employment"[tw] OR unemployment [MeSH] OR 
unemployment [tw] OR unemployed[tw] OR employability[tw] OR employable[tw] OR employee*[tw] OR "work capacity"[tw] OR 
"occupational health"[MesH] OR "occupational health services" [MeSH] OR "return to work"[tw] OR "retirement"[tw] OR "work 
status"[tw] OR "occupational medicine"[MeSH] OR "job satisfaction"[tw] OR "work ability"[tw] OR workability[tw] OR "work 
activity"[tw] OR "work retention"[tw] OR "job retention"[tw] OR "job loss"[tw] OR "job performance"[tw] OR "rehabilitation, 
vocational"[MeSH] OR "work rehabilitation"[tw] 
#3 (work[ti] OR worker*[tw] OR worki*[tw] OR workplace*[tw] OR worksite*[tw] OR occupation*[tw] OR "Occupational 
Groups"[Mesh]) AND ("disability management"[tw] OR "Rehabilitation"[Mesh:NoExp] OR "rehabilitation" [Subheading] OR 
"psychological intervention"[tw] OR "psychological interventions"[tw] OR "motivational interviewing" [tw] OR "self 
management"[tw] OR "behaviour change"[tw] OR "Occupational Therapy"[Mesh]) OR "work accommodation"[tw] OR "work 
modification"[tw] 
#4 #1 AND (#2 OR #3) 
#5 randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR placebo[tiab] OR drug therapy[sh] OR 
randomly[tiab] OR trial[tiab] OR groups[tiab] NOT (animals [mh] NOT humans [mh]) 
#6 (effect*[tw] OR control[tw] OR controls*[tw] OR controla*[tw] OR controle*[tw] OR controli*[tw] OR controll*[tw] OR 
evaluation*[tw] OR program*[tw]) OR "Cohort Studies"[Mesh] OR "Intervention Studies"[Mesh] OR "Comparative Study" 
[Publication Type] OR "Evaluation Studies as Topic"[Mesh:NoExp] OR "Evaluation Studies" [Publication Type] OR "follow up"[tw] 
#7 #4 AND #5 
#8 #4 AND #6 
#9 #7 OR #8  
Updated Search 9 December 2014 (by Kaisa Neuvonen) 
Search Query Items 
found 
#10 #9 AND ("2013/11/06"[Date - Entrez] : "3000"[Date - Entrez]) 154 
#9 #7 OR #8 3 249 
#8 #4 AND #6 3 018 
#7 #4 AND #5 1 033 
#6 (effect*[tw] OR control[tw] OR controls*[tw] OR controla*[tw] OR controle*[tw] OR controli*[tw] OR 
controll*[tw] OR evaluation*[tw] OR program*[tw]) OR "Cohort Studies"[Mesh] OR "Intervention Studies"[Mesh] 
OR "Comparative Study" [Publication Type] OR "Evaluation Studies as Topic"[Mesh:NoExp] OR "Evaluation 
Studies" [Publication Type] OR "follow up"[tw] 
11 397 
938 
#5 randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR placebo[tiab] OR drug 
therapy[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab] NOT (animals [mh] NOT humans [mh]) 
2 993 
018 
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#4 #1 AND (#2 OR #3) 4 626 
#3 (work[ti] OR worker*[tw] OR worki*[tw] OR workplace*[tw] OR worksite*[tw] OR occupation*[tw] OR 
"Occupational Groups"[Mesh]) AND ("disability management"[tw] OR "Rehabilitation"[Mesh:NoExp] OR 
"rehabilitation" [Subheading] OR "psychological intervention"[tw] OR "psychological interventions"[tw] OR 
"motivational interviewing" [tw] OR "self management"[tw] OR "behaviour change"[tw] OR "Occupational 
Therapy"[Mesh]) OR "work accommodation"[tw] OR "work modification"[tw] 
30 610 
#2 absenteeism[tw] OR absenteeism [MeSH] OR "work disability"[tw] OR "sick leave"[tw] OR "sick leave"[MeSH] OR 
"sickness absence"[tw] OR employment [MeSH] OR employment [tw] OR "re-employment"[tw] OR unemployment 
[MeSH] OR unemployment [tw] OR unemployed[tw] OR employability[tw] OR employable[tw] OR employee*[tw] 
OR "work capacity"[tw] OR "occupational health"[MesH] OR "occupational health services" [MeSH] OR "Return 
to work"[MeSH] OR "return to work"[tw] OR "retirement"[tw] OR "work status"[tw] OR "occupational 
medicine"[MeSH] OR "job satisfaction"[tw] OR "work ability"[tw] OR workability[tw] OR "work activity"[tw] OR 
"work retention"[tw] OR "job retention"[tw] OR "job loss"[tw] OR "job performance"[tw] OR "rehabilitation, 
vocational"[MeSH] OR "work rehabilitation"[tw] 
226 
105 
#1 HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tw] OR hiv-1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw] OR hiv 
infect*[tw] OR human immunodeficiency virus[tw] OR human immunedeficiency virus[tw] OR human immuno-
deficiency virus[tw] OR human immune-deficiency virus[tw] OR ((human immun*[tw]) AND (deficiency virus[tw])) 
OR acquired immunodeficiency syndrome[tw] OR acquired immunedeficiency syndrome[tw] OR acquired immuno-
deficiency syndrome[tw] OR acquired immune-deficiency syndrome[tw] OR ((acquired immun*[tw]) AND 
(deficiency syndrome[tw])) OR HIV/AIDS[tw] 
325 
944 
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B. Cochrane Central Register of Controlled Trials (CENTRAL) search strategy   
9 October 2012 (by Leena Isotalo) 
#1 
hiv or "hiv-1*" or "hiv-2*" or hiv1 or hiv2 or "hiv infect*" or "human immunodeficiency virus" or "human immunedeficiency virus" 
or "human immuno-deficiency virus" or "human immune-deficiency virus":ti,ab,kw (Word variations have been searched) 
9102 
#2 
MeSH descriptor: [HIV] explode all trees 
2250 
#3 
MeSH descriptor: [HIV Infections] explode all trees 
6728 
#4 
("human immun*" and "deficiency virus") or "acquired immunodeficiency syndrome" or "acquired immunedeficiency syndrome" or 
"acquired immuno-deficiency syndrome" or "acquired immune-deficiency syndrome" or ("acquired immun*" and "deficiency 
syndrome") or "HIV/AIDS" 
2340 
#5 
#1 or #2 or #3 or #4 
9863 
#6 
MeSH descriptor: [Absenteeism] explode all trees 
370 
#7 
MeSH descriptor: [Sick Leave] explode all trees 
334 
#8 
MeSH descriptor: [Employment] explode all trees 
958 
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#9 
MeSH descriptor: [Unemployment] explode all trees 
54 
#10 
MeSH descriptor: [Occupational Health] explode all trees 
318 
#11 
MeSH descriptor: [Occupational Health Services] explode all trees 
267 
#12 
MeSH descriptor: [Occupational Medicine] explode all trees 
57 
#13 
MeSH descriptor: [Rehabilitation, Vocational] explode all trees 
305 
#14 
absenteeism or "work disability" or "sick leave" or "sickness absence" or employment or "re-employment" or unemployment or 
unemployed or employability or employable or employee* or "work capacity" or "return to work" or "retirement" or "work status" or 
"job satisfaction" or "work ability" or workability or "work activity" or "work retention" or "job retention" or "job loss" or "job 
performance" or "work rehabilitation" 
6822 
#15 
#6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 
7297 
#16 
MeSH descriptor: [Occupational Groups] explode all trees 
5326 
#17 
MeSH descriptor: [Rehabilitation] this term only 
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270 
#18 
Any MeSH descriptor with qualifier(s): [Rehabilitation - RH] in all MeSH products 
11494 
#19 
MeSH descriptor: [Occupational Therapy] explode all trees 
452 
#20 
work*:ti (Word variations have been searched) 
4338 
#21 
worker* or worki* or workplace* or worksite* or occupation* 
16400 
#22 
"psychological intervention" or "psychological interventions" or "motivational interviewing" or "self management" or "behaviour 
change" or accommodation or modification 
12075 
#23 
#16 or #20 or #21 
22100 
#24 
"disability management" 
18 
#25 
#17 or #18 or #19 or #22 or #24 
23331 
#26 
#23 and #25 
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3171 
#27 
#15 or #26 
9556 
#28 
#5 and #27 
245 
limited to: 
Cochrane Central Register of Controlled Trials (Central) 
80 
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C. EMBASE search strategy   
20 September 2012 (by Leena Isotalo) 
(#1) 
'human immunodeficiency virus infection'/exp OR 'human immunodeficiency virus'/exp OR hiv:ab,ti OR 'hiv-1':ab,ti OR 'hiv-2':ab,ti 
OR 'human immunodeficiency virus':ab,ti OR 'human immuno-deficiency virus':ab,ti OR 'human immunedeficiency virus':ab,ti OR 
'human immune-deficiency virus':ab,ti OR 'acquired immune-deficiency syndrome':ab,ti OR 'acquired immunedeficiency 
syndrome':ab,ti OR 'acquired immunodeficiency syndrome':ab,ti OR 'acquired immuno-deficiency syndrome':ab,ti OR 'hiv/aids':ab,ti 
364,281 
(#2) 
'absenteeism'/de OR 'medical leave'/de OR 'work disability'/de OR 'employment'/exp OR 'unemployment'/de OR 'work capacity'/de 
OR 'occupational health'/de OR 'employability'/de OR 'job accommodation'/de OR 'vocational rehabilitation'/de OR 'occupational 
health service'/de OR 'occupational health nursing'/de OR 'occupational medicine'/de OR 'industrial medicine'/de OR 'job 
adaptation'/de OR 'retirement'/de OR 'job satisfaction'/de OR 'job performance'/de OR absenteeism:ab,ti OR 'work disability':ab,ti OR 
'sick leave':ab,ti OR 'sickness absence':ab,ti OR employment:ab,ti OR 're-employment':ab,ti OR unemployment:ab,ti OR 
unemployed:ab,ti OR employability:ab,ti OR employable:ab,ti OR employee*:ab,ti OR 'work capacity':ab,ti OR 'occupational health 
services':ab,ti OR 'return to work':ab,ti OR retirement:ab,ti OR 'work status':ab,ti OR 'job satisfaction':ab,ti OR 'work ability':ab,ti OR 
workability:ab,ti OR 'work activity':ab,ti OR 'work retention':ab,ti OR 'job retention':ab,ti OR 'job loss':ab,ti OR 'job performance':ab,ti 
OR 'vocational rehabilitation':ab,ti OR 'work rehabilitation':ab,ti OR 'work accommodation':ab,ti OR 'work modification':ab,ti 
238,611 
(#3) 
work*:ab,ti OR occupation*:ab,ti OR 'work environment'/de OR 'work'/de OR 'workplace'/exp OR 'occupation and occupation related 
phenomena'/de OR 'occupation'/exp OR 'occupational health'/exp AND ('disability management':ab,ti OR rehabilitation:de,ab,ti OR 
'psychological intervention':ab,ti OR 'psychological interventions':ab,ti OR 'motivational interviewing':ab,ti OR 'self 
management':ab,ti OR behavio* NEAR/3 chang* OR 'occupational therapy') 
52,567 
(#4) 
#1 AND (#2 OR #3) 
5,044 
(#5) 
random* OR factorial* OR crossover* OR cross NEXT/1 over* OR placebo* OR doubl* NEAR/1 blind* OR singl* NEAR/1 blind 
OR assign* OR allocat* OR volunteer* OR 'crossover procedure'/de OR 'double-blind procedure'/de OR 'single-blind procedure'/de 
OR 'randomized controlled trial'/de 
1,405,159 
(#6) 
effect* OR control* OR evaluation* OR program* OR 'cohort analysis'/de OR 'intervention study'/de OR 'comparative study'/de OR 
'comparative effectiveness'/de OR 'intermethod comparison'/de OR 'follow up' 
12,732,170 
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(#7) 
#4 AND #5 
456 
(#8) 
#4 AND #6 
3,435 
(#9) 
#7 OR #8 
3,497 
(#10) 
'editorial'/it OR 'letter'/it OR 'note'/it OR 'short survey'/it OR 'nonhuman'/de 
5,767,119 
(#11) 
#9 NOT #10 
3,228 
(#12) 
#11 AND [embase]/lim 
2,110 
Updated Search 9 December 2014 (by Kaisa Neuvonen) 
(#13) 
#11 AND [embase]/lim AND [6-11-2013]/sd NOT [9-12-2014]/sd 
354 
(#12) 
#11 AND [embase]/lim 
2,519 
(#11) 
#9 NOT #10 
3,434 
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(#10) 
'editorial'/it OR 'letter'/it OR 'note'/it OR 'short survey'/it OR 'nonhuman'/de 
6,412,344 
(#9) 
#7 OR #8 
3,686 
(#8) 
#4 AND #6 
3,588 
(#7) 
#4 AND #5 
575 
(#6) 
effect* OR control* OR evaluation* OR program* OR 'cohort analysis'/de OR 'intervention study'/de OR 'comparative study'/de OR 
'comparative effectiveness'/de OR 'intermethod comparison'/de OR 'follow up' 
12,986,661 
(#5) 
random* OR factorial* OR crossover* OR cross NEXT/1 over* OR placebo* OR doubl* NEAR/1 blind* OR singl* NEAR/1 blind 
OR assign* OR allocat* OR volunteer* OR 'crossover procedure'/de OR 'double-blind procedure'/de OR 'single-blind procedure'/de 
OR 'randomized controlled trial'/de 
1,674,549 
(#4) 
#1 AND (#2 OR #3) 
5,936 
(#3) 
work*:ab,ti OR occupation*:ab,ti OR 'work environment'/de OR 'work'/de OR 'workplace'/exp OR 'occupation and occupation related 
phenomena'/de OR 'occupation'/exp OR 'occupational health'/exp AND ('disability management':ab,ti OR rehabilitation:de,ab,ti OR 
'psychological intervention':ab,ti OR 'psychological interventions':ab,ti OR 'motivational interviewing':ab,ti OR 'self 
management':ab,ti OR behavio* NEAR/3 chang* OR 'occupational therapy') 
61,328 
(#2) 
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'absenteeism'/de OR 'medical leave'/de OR 'work disability'/de OR 'employment'/exp OR 'unemployment'/de OR 'work capacity'/de 
OR 'occupational health'/de OR 'employability'/de OR 'job accommodation'/de OR 'vocational rehabilitation'/de OR 'occupational 
health service'/de OR 'occupational health nursing'/de OR 'occupational medicine'/de OR 'industrial medicine'/de OR 'job 
adaptation'/de OR 'retirement'/de OR 'job satisfaction'/de OR 'job performance'/de OR absenteeism:ab,ti OR 'work disability':ab,ti OR 
'sick leave':ab,ti OR 'sickness absence':ab,ti OR employment:ab,ti OR 're-employment':ab,ti OR unemployment:ab,ti OR 
unemployed:ab,ti OR employability:ab,ti OR employable:ab,ti OR employee*:ab,ti OR 'work capacity':ab,ti OR 'occupational health 
services':ab,ti OR 'return to work':ab,ti OR retirement:ab,ti OR 'work status':ab,ti OR 'job satisfaction':ab,ti OR 'work ability':ab,ti OR 
workability:ab,ti OR 'work activity':ab,ti OR 'work retention':ab,ti OR 'job retention':ab,ti OR 'job loss':ab,ti OR 'job performance':ab,ti 
OR 'vocational rehabilitation':ab,ti OR 'work rehabilitation':ab,ti OR 'work accommodation':ab,ti OR 'work modification':ab,ti 
262,028 
(#1) 
'human immunodeficiency virus infection'/exp OR 'human immunodeficiency virus'/exp OR hiv:ab,ti OR 'hiv-1':ab,ti OR 'hiv-2':ab,ti 
OR 'human immunodeficiency virus':ab,ti OR 'human immuno-deficiency virus':ab,ti OR 'human immunedeficiency virus':ab,ti OR 
'human immune-deficiency virus':ab,ti OR 'acquired immune-deficiency syndrome':ab,ti OR 'acquired immunedeficiency 
syndrome':ab,ti OR 'acquired immunodeficiency syndrome':ab,ti OR 'acquired immuno-deficiency syndrome':ab,ti OR 'hiv/aids':ab,ti 
404,528 
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D. OSH UPDATE search strategy   
25 September 2012 (by Leena Isotalo) 
#1 3152 GW{hiv OR "hiv-1*" OR "hiv-2*" OR hiv1 OR hiv2 OR "HIV/AIDS" OR HUMAN IMMUNODEFICIENCY VIRUS 
OR HUMAN IMMUNEDEFICIENCY VIRUS OR HUMAN IMMUNE-DEFICIENCY VIRUS OR HUMAN 
IMMUNO-DEFICIENCY VIRUS OR HUMAN IMMUN* DEFICIENCY VIRUS OR ACQUIRED 
IMMUNODEFICIENCY SYNDROME OR ACQUIRED IMMUNEDEFICIENCY SYNDROME OR ACQUIRED 
IMMUNO-DEFICIENCY SYNDROME OR ACQUIRED IMMUNE-DEFICIENCY SYNDROME OR ACQUIRED 
IMMUN* DEFICIENCY SYNDROME} 
#2 89805 GW{absenteeism OR work disability OR sick leave OR sickness absence OR employment OR re-employment OR 
unemployment OR unemployed OR employability OR employable OR employee* OR work capacity OR occupational 
health service* OR return-to-work OR retirement OR work status OR job satisfaction OR work ability OR workability 
OR work activity OR work retention OR job retention OR job loss OR job performance OR vocational rehabilitation OR 
work rehabilitation} 
#3 47230 GW{disability OR rehabilitation OR psycholog* OR motivational OR self management OR behaviour OR behavior OR 
therapy OR work accommodation OR work modification} 
#4 87611 GW{workplace* OR worksite* OR work place* OR work site* OR organisation* OR organization*} 
#5 19111 GW{occupation OR occupations} 
#6 392334 GW{random* OR trial* OR groups OR effect* OR effici* OR control* OR evaluat* OR program* OR cohort* OR 
intervention* OR compar* OR follow-up} 
#7 732455 DC{OUCISD OR OUHSEL OR OUNIOC OR OUNIOS OR OURILO} 
#8 193459 #2 OR #3 OR #4 OR #5 
#9 1355 #1 AND #8 
#10 970 #9 AND #6 
#11 764 #10 AND #7 
 
